Data / Research funding / Eye Disease and Disorders of Vision
Eye Disease and Disorders of Vision: 4,088 NIH awards ($4.4B) to 486 organizations
4,088 NIH awards ($4.4B) in the NIH spending category Eye Disease and Disorders of Vision, to 486 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 4,088 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| DRCR Retina Network | NIH | National Eye Institute | 2021 to 2025 | $43,226,123 | September 30, 2002 | December 31, 2028 | GLASSMAN, ADAM R | reporter.nih.gov |
| Pediatric Eye Disease Investigator Group Coordinating Center | NIH | National Eye Institute | 2021 to 2025 | $33,066,572 | May 1, 1997 | December 31, 2028 | KRAKER, RAYMOND | reporter.nih.gov |
| UniProt: A Protein Sequence and Function Resource for Biomedical Science | NIH | National Human Genome Research Institute | 2021 to 2025 | $29,053,046 | September 18, 2014 | May 31, 2027 | BATEMAN, ALEX | reporter.nih.gov |
| Center for Innovative NeuroTech Advancement - CINTA (17041 Stanford) | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $27,603,179 | September 30, 2022 | June 30, 2027 | SCHACHTER, STEVEN C. | reporter.nih.gov |
| Iron-CLAD: securely advancing AoU participant characterization with proven platforms and collaborations | NIH | Office of the Director, National Institutes of Health | 2023 to 2025 | $26,401,438 | April 15, 2024 | March 31, 2026 | HAENDEL, MELISSA A | reporter.nih.gov |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| THE SCOPE OF THIS PROCUREMENT IS TO DEVELOP, REFINE, DEPLOY, VALIDATE, MAINTAIN, AND SUPPORT A NEXT-GENERATION CLOUD-BASED ELECTRONIC VISION-RELATED QUALITY OF LIFE EPRO PLATFORM FOR USE BY NIH AND IT | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $21,721,781 | September 29, 2025 | September 28, 2026 | STARK, KAREN A. | reporter.nih.gov |
| The Illinois Precision Medicine Consortium (IPMC) All of Us Research Program Site | NIH | Office of the Director, National Institutes of Health | 2023 to 2025 | $18,737,000 | September 1, 2023 | August 31, 2026 | AHSAN, HABIBUL | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2021 to 2024 | $17,711,217 | September 1, 2019 | August 31, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| Replication Study of Off-Target Assays for Guide RNAs in CRISPR-Based Therapeutics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,077,732 | December 1, 2024 | April 30, 2025 | SAHA, KRISHANU | reporter.nih.gov |
| Clarifying the Optimal Application of SLT Therapy (COAST) Trial | NIH | National Eye Institute | 2021 to 2024 | $15,288,624 | September 30, 2020 | August 31, 2025 | WISNIEWSKI, STEPHEN R | reporter.nih.gov |
| NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa | NIH | National Eye Institute | 2022 to 2025 | $15,187,946 | March 17, 2022 | July 31, 2027 | KONG, XIANGRONG | reporter.nih.gov |
| Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Surveys in India (LASI) | NIH | National Institute on Aging | 2021 to 2025 | $13,167,007 | September 15, 2015 | April 30, 2026 | LEE, JINKOOK | reporter.nih.gov |
| The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2) | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $12,401,383 | September 16, 2011 | July 31, 2027 | BRAUN, ROBERT E | reporter.nih.gov |
| All of Us Coast-to-Coast Strong recrUitment, Retention, and Facilitation (C2C SURF) | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $10,946,000 | May 1, 2024 | May 31, 2026 | OHNO-MACHADO, LUCILA | reporter.nih.gov |
| Bridging Function, Connectivity, and Transcriptomics of Mouse Cortical Neurons | NIH | National Institute of Mental Health | 2022 to 2025 | $10,302,121 | September 1, 2022 | June 30, 2027 | ARKHIPOV, ANTON | reporter.nih.gov |
| Visual Sciences Center of Biomedical Research Excellence | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,360,390 | March 20, 2022 | January 31, 2027 | RAMAMURTHY, VISVANATHAN | reporter.nih.gov |
| Therapeutic gene editing and multimodal imaging in juvenile macular degeneration | NIH | National Eye Institute | 2021 to 2024 | $8,710,741 | June 1, 2020 | May 31, 2026 | TSANG, STEPHEN H | reporter.nih.gov |
| Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $8,348,817 | September 15, 2022 | May 31, 2027 | ALBER, JESSICA | reporter.nih.gov |
| Immunotherapy for Ocular Surface Diseases | NIH | National Eye Institute | 2021 to 2025 | $8,312,140 | February 1, 2021 | December 31, 2026 | JAIN, SANDEEP | reporter.nih.gov |
| Rutgers University CounterACT Center of Excellence | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $7,988,704 | September 15, 2006 | August 31, 2025 | LASKIN, JEFFREY D | reporter.nih.gov |
| Restoring Vision with High-Fidelity Nonsense Codon Correction | NIH | National Eye Institute | 2021 to 2025 | $7,812,597 | February 1, 2021 | November 30, 2026 | PATTNAIK, BIKASH RANJAN | reporter.nih.gov |
| University of California Launching Future Leaders in Global Health Research Training Program | NIH | Fogarty International Center | 2021 to 2025 | $7,742,746 | July 1, 2025 | June 30, 2026 | COHEN, CRAIG R | reporter.nih.gov |
| IGF::OT::IGFEMMES NEIS-V | NIH | Office of the Director, National Institutes of Health | 2021 | $7,315,897 | November 1, 2016 | October 31, 2021 | HAMMEL, KERI | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer''s disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2025 | $7,155,353 | September 1, 2019 | April 30, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma | NIH | National Eye Institute | 2021 to 2025 | $7,031,142 | September 30, 2021 | July 31, 2027 | MEYER, JASON STEPHEN | reporter.nih.gov |
| Primary Open Angle African-American Glaucoma Genetics Study Renewal | NIH | National Eye Institute | 2021 to 2025 | $6,924,827 | April 1, 2014 | March 31, 2026 | O'BRIEN, JOAN M | reporter.nih.gov |
| MUST Data Science Research Hub (MUDSReH) | NIH | Fogarty International Center | 2021 to 2025 | $6,511,809 | September 15, 2021 | June 30, 2027 | KAGGWA, FRED | reporter.nih.gov |
| Whole Person Reference Physiome Research and Coordination Center | NIH | National Center for Complementary & Integrative Health | 2025 | $6,476,031 | August 8, 2025 | July 31, 2028 | SNYDER, MICHAEL P. | reporter.nih.gov |
| Traveling Waves in Neocortical Circuits: Mechanisms, Computational Roles in Sensory Processing, and Impact on Sensory Perception | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $5,980,142 | August 31, 2023 | July 31, 2026 | REYNOLDS, JOHN H | reporter.nih.gov |
| Assessing how ocular surface nerves, immune cells, and epithelial cells communicate to encourage neuro-immune homeostasis | NIH | National Eye Institute | 2022 to 2025 | $5,960,366 | September 30, 2022 | August 31, 2027 | ST LEGER, ANTHONY J | reporter.nih.gov |
| Study of Latinos (SOL) Ojos | NIH | National Eye Institute | 2021 to 2023 | $5,789,999 | September 1, 2019 | July 31, 2025 | JOSLIN, CHARLOTTE E | reporter.nih.gov |
| I-TRUST: Implementation of Teleophthalmology in Rural Health Systems Study | NIH | National Eye Institute | 2021 to 2025 | $5,785,363 | September 30, 2021 | August 31, 2027 | LIU, YAO | reporter.nih.gov |
| Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function | NIH | National Eye Institute | 2021 to 2025 | $5,733,511 | September 30, 2021 | January 31, 2027 | MCGREGOR, JULIETTE ELIZABETH | reporter.nih.gov |
| Descemet Endothelial Thickness Comparison Trial (DETECT) | NIH | National Eye Institute | 2021 to 2025 | $5,663,165 | April 1, 2021 | March 31, 2027 | ROSE-NUSSBAUMER, JENNIFER | reporter.nih.gov |
| Understanding neural control of the ocular surface | NIH | National Eye Institute | 2022 to 2025 | $5,561,710 | September 30, 2022 | August 31, 2027 | JENKINS, MICHAEL W. | reporter.nih.gov |
| Optoretinography: All-optical measures of functional activity in the human retina | NIH | National Eye Institute | 2021 to 2025 | $5,162,127 | September 30, 2021 | August 31, 2026 | SABESAN, RAMKUMAR | reporter.nih.gov |
| All of Us Southern California Consortium (AoUSCC) | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $5,137,147 | May 1, 2024 | July 31, 2026 | ANTON-CULVER, HODA A | reporter.nih.gov |
| Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US Project | NIH | National Eye Institute | 2021 to 2025 | $5,084,488 | May 1, 2010 | August 31, 2027 | LI, TIANJING | reporter.nih.gov |
| Central and Peripheral Mechanisms of Corneal Pain | NIH | National Eye Institute | 2022 to 2025 | $5,081,730 | September 30, 2022 | August 31, 2027 | MENG, IAN D | reporter.nih.gov |
| Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents | NIH | National Eye Institute | 2022 to 2025 | $5,054,648 | September 30, 2022 | August 31, 2027 | SABAN, DANIEL RAPHAEL | reporter.nih.gov |
| Medical Scientist Training Program | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $4,945,201 | July 1, 1975 | June 30, 2025 | HUANG, ALEX YEE-CHEN | reporter.nih.gov |
| Achieving specificity in imaging neurodegeneration with visible light Optical Coherence Tomography | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,798,178 | September 15, 2024 | September 14, 2027 | SRINIVASAN, VIVEK JAY | reporter.nih.gov |
| Effects of cornea epithelial barrier disruption on the cornea trigeminal neural circuit | NIH | National Eye Institute | 2022 to 2025 | $4,737,185 | September 30, 2022 | August 31, 2027 | PFLUGFELDER, STEPHEN C | reporter.nih.gov |
| Project Prakash: Development of Object Perception After Late Sight Onset | NIH | National Eye Institute | 2021 to 2025 | $4,719,208 | February 1, 2011 | August 31, 2029 | SINHA, PAWAN | reporter.nih.gov |
| Novel retinal higher-order capillary hemodynamics imaging for detecting cerebral small vessel disease | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,719,171 | September 15, 2024 | September 14, 2027 | WANG, JIANHUA | reporter.nih.gov |
| Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,693,682 | February 15, 2021 | January 31, 2027 | BENKE, TIMOTHY A | reporter.nih.gov |
| Cortical-Basal Ganglia Speech Networks | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,623,047 | September 30, 2020 | June 30, 2025 | RICHARDSON, ROBERT MARK | reporter.nih.gov |
| Sensory Motor Transformations in Human Cortex | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,572,652 | August 15, 2021 | July 31, 2026 | ANDERSEN, RICHARD A | reporter.nih.gov |
| Neural Mechanisms of Colored Light Driven Analgeisa | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $4,572,599 | September 19, 2024 | August 31, 2027 | MAUCK, MATTHEW CHRISTOPHER | reporter.nih.gov |
| Delaying the onset of nearsightedness study – coordinating center | NIH | National Eye Institute | 2025 | $4,539,043 | September 15, 2025 | July 31, 2030 | JORDAN, LISA A | reporter.nih.gov |
| Diabetes Endothelial Keratoplasty Study: Impact of Diabetes on Corneal Transplant Success and Cell Loss | NIH | National Eye Institute | 2021 to 2025 | $4,496,381 | May 1, 2021 | April 30, 2026 | GAL, ROBIN L | reporter.nih.gov |
| Underpinnings of corneal innervation: anatomical, molecular, and functional studies of corneal sensory afferents in physiologic and pathologic states | NIH | National Eye Institute | 2022 to 2025 | $4,440,467 | September 30, 2022 | August 31, 2027 | ROMPOLAS, PANTELEIMON | reporter.nih.gov |
| Innate and Adaptive Immunity in the Pathogenesis of Glaucoma | NIH | National Eye Institute | 2021 to 2025 | $4,329,067 | September 1, 2021 | June 30, 2026 | CHEN, DONG FENG | reporter.nih.gov |
| Alleviation of ER stress as a translational strategy to curb ocular viral infections | NIH | National Eye Institute | 2022 to 2025 | $4,325,995 | March 1, 2022 | December 31, 2026 | SHUKLA, DEEPAK | reporter.nih.gov |
| Highly Efficient MRI Pulse Sequences for High Resolution Physiological and Functional Brain Imaging | NIH | National Institute of Mental Health | 2021 to 2023 | $4,281,145 | September 20, 2021 | August 31, 2025 | FEINBERG, DAVID ALAN | reporter.nih.gov |
| Retinoids in Vision | NIH | National Eye Institute | 2021 to 2025 | $4,266,288 | August 1, 1992 | August 31, 2028 | PALCZEWSKI, KRZYSZTOF | reporter.nih.gov |
| A selective angiogenesis blocker to treat retinopathy of prematurity | NIH | National Eye Institute | 2021 to 2023 | $4,248,825 | February 1, 2019 | December 31, 2025 | LI, WEI | reporter.nih.gov |
| Novel Extended Release Glaucoma Therapy for Once Daily Dosing | NIH | National Eye Institute | 2021 to 2024 | $4,201,359 | March 1, 2020 | February 28, 2026 | JABLONSKI, MONICA M | reporter.nih.gov |
| Center Core Grant for Vision Research | NIH | National Eye Institute | 2021 to 2025 | $4,161,940 | July 1, 1997 | August 31, 2026 | ARSHAVSKY, VADIM Y | reporter.nih.gov |
| Parasitic Ulcer Treatment Trial | NIH | National Eye Institute | 2023 to 2025 | $4,068,111 | September 30, 2023 | March 31, 2028 | KEENAN, JEREMY DAVID | reporter.nih.gov |
| Spectacle Prescribing in Early Childhood (SPEC) | NIH | National Eye Institute | 2021 to 2023 | $4,053,414 | June 1, 2019 | May 31, 2026 | TWELKER, JOHN DANIEL | reporter.nih.gov |
| Diabetes Endothelial Keratoplasty Study(DEKS): Impact of Diabetes on Corneal Transplant Success and Cell Loss | NIH | National Eye Institute | 2021 to 2025 | $4,021,141 | May 1, 2021 | April 30, 2027 | LASS, JONATHAN H | reporter.nih.gov |
| Development of GPER Agonists as Therapeuticsfor Cutaneous and Uveal Melanoma | NIH | National Cancer Institute | 2022 to 2023 | $4,000,000 | March 16, 2018 | March 31, 2024 | GARYANTES, TINA | reporter.nih.gov |
| ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,900,002 | March 21, 2022 | December 31, 2026 | RITCHLIN, CHRISTOPHER TREVOR | reporter.nih.gov |
| Multicellular Mechanisms Driving Axon Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,884,176 | May 17, 2021 | April 30, 2029 | CAVALLI, VALERIA | reporter.nih.gov |
| Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $3,859,697 | September 30, 2021 | July 31, 2027 | WANG, DANNY JJ | reporter.nih.gov |
| Organization and Development of Functional Representations in Visual Cortex | NIH | National Eye Institute | 2021 to 2025 | $3,845,525 | August 1, 1996 | August 31, 2029 | FITZPATRICK, DAVID | reporter.nih.gov |
| Models for Therapy of Hereditary Retinal Degeneration | NIH | National Eye Institute | 2021 to 2025 | $3,791,872 | December 1, 1992 | December 31, 2029 | BELTRAN, WILLIAM A. | reporter.nih.gov |
| SCGE Disease Models Studies Supplement: Development of LNP-mediated based editing to treat Leber Congenital Amaurosis (LCA) for vision restoration in mouse model | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $3,783,475 | September 18, 2018 | July 31, 2023 | CHEN, ZHENG-YI | reporter.nih.gov |
| A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy | NIH | National Eye Institute | 2021 to 2024 | $3,781,701 | September 30, 2021 | July 31, 2026 | FU, YINGBIN | reporter.nih.gov |
| Modulating Glial Fate and Function in Development and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,751,910 | May 1, 2020 | April 30, 2028 | TESAR, PAUL JOSEPH | reporter.nih.gov |
| P30 Core Grant For Vision Research | NIH | National Eye Institute | 2021 to 2025 | $3,735,564 | September 1, 1997 | August 31, 2029 | MITCHELL, CLAIRE H | reporter.nih.gov |
| Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial | NIH | National Eye Institute | 2021 to 2023 | $3,733,343 | May 1, 2019 | April 30, 2026 | ACHARYA, NISHA | reporter.nih.gov |
| Differentiation of Clinical Phenotypes of Inflammatory and Neuropathic Ocular Pain Conditions with Morphologic Measures and Functional Brain Imaging | NIH | National Eye Institute | 2022 to 2025 | $3,722,281 | September 30, 2022 | August 31, 2027 | MOULTON, ERIC ALAN | reporter.nih.gov |
| Human Brain Single-Cell Genomics Explorer | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,712,398 | September 1, 2025 | August 31, 2028 | ZHU, JINGCHUN | reporter.nih.gov |
| Translational Gene Therapy for CNGB1 Retinitis Pigmentosa | NIH | National Eye Institute | 2021 to 2022 | $3,709,328 | April 1, 2018 | July 31, 2025 | PETERSEN-JONES, SIMON | reporter.nih.gov |
| Early Feasibility Clinical Trial of a Visual Cortical Prosthesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $3,701,816 | September 15, 2018 | March 31, 2025 | PATEL, UDAY KIRIT | reporter.nih.gov |
| Network-based neuromodulation for posterior cortical atrophy | NIH | National Institute on Aging | 2025 | $3,664,645 | August 1, 2025 | July 31, 2029 | HAMPSTEAD, BENJAMIN MICHAEL | reporter.nih.gov |
| Visual biofeedback to reduce head motion during MRI scans | NIH | National Institute of Mental Health | 2021 to 2022 | $3,644,531 | September 11, 2019 | May 31, 2024 | ROTHNEY, MEGAN PEARL | reporter.nih.gov |
| MAPPING RETINOTECTAL CIRCUITS FOR VISUAL-EVOKED INNATE BEHAVIORS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,616,494 | August 15, 2021 | July 31, 2027 | DUAN, XIN | reporter.nih.gov |
| ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial | NIH | National Eye Institute | 2021 to 2022 | $3,613,158 | September 30, 2018 | August 31, 2025 | HOLBROOK, JANET T. | reporter.nih.gov |
| Understanding the clinical impact of cumulative genetic risk to glaucoma | NIH | National Eye Institute | 2021 to 2025 | $3,591,952 | July 1, 2021 | March 31, 2030 | PASQUALE, LOUIS ROBERT | reporter.nih.gov |
| Experience-dependent Cellular Plasticity Mechanisms | NIH | National Eye Institute | 2021 to 2025 | $3,578,100 | January 1, 2021 | December 31, 2025 | CLINE, HOLLIS T. | reporter.nih.gov |
| Ocular Immune Regulation by Mesenchymal Stem Cells | NIH | National Eye Institute | 2021 to 2025 | $3,542,949 | April 1, 2015 | September 14, 2028 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Insights Into Immune-Related Diseases Born from Population Genomics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,513,383 | July 6, 2010 | July 31, 2030 | NORMAN, PAUL JOHN | reporter.nih.gov |
| Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk? | NIH | National Eye Institute | 2021 to 2025 | $3,499,675 | January 1, 2021 | November 30, 2025 | JOHN, SIMON W | reporter.nih.gov |
| Visuomotor Prosthetic for Paralysis | NIH | National Eye Institute | 2021 to 2025 | $3,468,480 | May 1, 2021 | March 31, 2026 | ANDERSEN, RICHARD A | reporter.nih.gov |
| Mechanisms of Pain and Photophobia in Migraine and Dry Eye | NIH | National Eye Institute | 2022 to 2025 | $3,466,540 | September 30, 2022 | August 31, 2027 | AICHER, SUE A | reporter.nih.gov |
| Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis | NIH | National Institute on Aging | 2023 to 2024 | $3,420,052 | September 30, 2015 | August 31, 2025 | SARRAF, STELLA | reporter.nih.gov |
| Pathogenesis of Glaucomatous Optic Nerve Damage | NIH | National Eye Institute | 2021 to 2025 | $3,417,748 | August 1, 1977 | June 30, 2026 | QUIGLEY, HARRY ALAN | reporter.nih.gov |
| NEIGHBORHOOD Consortium for POAG Genetics | NIH | National Eye Institute | 2021 to 2025 | $3,388,093 | August 1, 2012 | January 31, 2027 | WIGGS, JANEY L | reporter.nih.gov |
| Multi-method investigation and characterization of the ocular microbiome | NIH | National Eye Institute | 2023 to 2025 | $3,357,381 | July 1, 2023 | June 30, 2027 | DE PAIVA, CINTIA S. | reporter.nih.gov |
| University of Utah Core Vision Research Grant | NIH | National Eye Institute | 2021 to 2025 | $3,354,219 | April 1, 2005 | June 30, 2029 | BERNSTEIN, PAUL STEVEN | reporter.nih.gov |
| Unraveling the molecular pathology of retinal degeneration through single cell genomics | NIH | National Eye Institute | 2021 to 2025 | $3,347,817 | June 1, 2021 | May 31, 2027 | AYYAGARI, RADHA | reporter.nih.gov |
| Mechanisms of Sensitization in High Risk Corneal Grafts | NIH | National Eye Institute | 2021 to 2025 | $3,336,083 | August 1, 2000 | July 31, 2027 | DANA, REZA | reporter.nih.gov |
| Dense Analysis of Cortical Circuit Dysfunction in the MECP2-duplication Syndrome of Autism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,332,806 | January 1, 2021 | December 31, 2025 | SMIRNAKIS, STELIOS MANOLIS | reporter.nih.gov |
| Development of domains in inferotemporal cortex | NIH | National Eye Institute | 2021 to 2025 | $3,321,207 | August 1, 2015 | March 31, 2027 | LIVINGSTONE, MARGARET S | reporter.nih.gov |
| Azithromycin Reduction to Reach Elimination of Trachoma | NIH | National Eye Institute | 2021 to 2024 | $3,313,000 | May 1, 2020 | April 30, 2026 | OLDENBURG, CATHERINE ELIZABETH | reporter.nih.gov |
| Defining bacterial members of the ocular surface microbiome and assessing stability over time | NIH | National Eye Institute | 2023 to 2025 | $3,305,844 | July 1, 2023 | June 30, 2027 | ST LEGER, ANTHONY J | reporter.nih.gov |
| Engineering AAV for safe and efficient gene delivery to the human retina | NIH | National Eye Institute | 2021 to 2025 | $3,303,996 | June 1, 2014 | June 30, 2029 | BOYE, SHANNON ELIZABETH | reporter.nih.gov |
| Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2025 | $3,286,256 | September 15, 2023 | May 31, 2028 | BERKOWITZ, BRUCE A. | reporter.nih.gov |
| Precision Medicine for Inherited Retinal Degenerations | NIH | National Eye Institute | 2021 to 2025 | $3,285,691 | July 8, 1999 | July 31, 2028 | PIERCE, ERIC A | reporter.nih.gov |
| Glaucoma Drainage Device and Endothelial Cell Density Loss Compare (DECLARE) Trial | NIH | National Eye Institute | 2023 to 2025 | $3,279,404 | April 1, 2023 | March 31, 2028 | HAN, YING | reporter.nih.gov |
| Effects of Abnormal Early Experience on IT Circuitry | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,270,307 | September 22, 2021 | August 31, 2026 | LIVINGSTONE, MARGARET S | reporter.nih.gov |
| SCD REVIVE - Retina to Evaluate Vaso occlusion In the Vasculature of the Eye | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,242,672 | April 10, 2022 | March 31, 2027 | GLASSBERG, JEFFREY AVINS | reporter.nih.gov |
| Retinal Ganglion Cell Replacement in Optic Neuropathies | NIH | National Eye Institute | 2021 to 2024 | $3,242,042 | September 30, 2018 | August 31, 2024 | GOLDBERG, JEFFREY L | reporter.nih.gov |
| Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration | NIH | National Eye Institute | 2021 to 2025 | $3,241,037 | January 1, 2021 | December 31, 2026 | YIU, GLENN | reporter.nih.gov |
| Vestibular and Visual Control of Eye Movement | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,237,502 | September 30, 1999 | June 30, 2025 | RAYMOND, JENNIFER L | reporter.nih.gov |
| Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis | NIH | National Cancer Institute | 2021 to 2025 | $3,231,041 | August 9, 2021 | July 31, 2026 | SMALLEY, KEIRAN | reporter.nih.gov |
| Neuronal mechanisms of image processing in the early visual pathway | NIH | National Eye Institute | 2021 to 2025 | $3,230,700 | September 1, 1983 | May 31, 2029 | ALONSO, JOSE MANUEL | reporter.nih.gov |
| NEI Center Core Grant for Vision Research | NIH | National Eye Institute | 2021 to 2025 | $3,229,937 | September 1, 2023 | April 30, 2028 | ZANGWILL, LINDA M | reporter.nih.gov |
| Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease | NIH | National Eye Institute | 2021 to 2025 | $3,225,003 | April 1, 2019 | June 30, 2028 | CHERRY, TIMOTHY JOEL | reporter.nih.gov |
| Supplement: Topological bridges between circuits, models, and behavior | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $3,222,134 | May 1, 2021 | April 30, 2024 | RUNYAN, CAROLINE ANNE | reporter.nih.gov |
| Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,216,546 | March 1, 2021 | February 28, 2027 | WEISMAN, GARY ANDREW | reporter.nih.gov |
| Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen) | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $3,205,764 | June 1, 2020 | November 30, 2025 | SHIBOSKI, CAROLINE HELENE | reporter.nih.gov |
| Clinical glaucoma management enabled by visible-light OCT | NIH | National Eye Institute | 2021 to 2025 | $3,200,220 | September 30, 2021 | June 30, 2027 | ZHANG, HAO F | reporter.nih.gov |
| Cellular-level Vascular Oculomics (CVO) for monitoring systemic vascular health | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $3,197,511 | September 15, 2024 | September 14, 2026 | FAWZI, AMANI A | reporter.nih.gov |
| Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,190,228 | July 1, 2022 | June 30, 2027 | DEAN, DEBORAH ANNE | reporter.nih.gov |
| Signaling Mechanisms of Lens Development | NIH | National Eye Institute | 2021 to 2025 | $3,164,271 | January 1, 2006 | September 14, 2028 | ZHANG, XIN | reporter.nih.gov |
| Genetics of HSV DNA Replication | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,163,897 | December 1, 1984 | December 31, 2025 | WELLER, SANDRA K | reporter.nih.gov |
| Developing an Optogenetics Technology Based on Natural Potassium-selective Channelrhodopsins | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $3,145,118 | September 1, 2023 | August 31, 2026 | SPUDICH, JOHN LEE | reporter.nih.gov |
| Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial | NIH | National Eye Institute | 2021 to 2024 | $3,131,620 | August 1, 2020 | July 31, 2025 | NEWMAN-CASEY, PAULA ANNE | reporter.nih.gov |
| A Massive Library of AAVs to Target Transcriptionally-Defined Primate Cell Types | NIH | National Institute of Mental Health | 2023 to 2024 | $3,125,402 | September 1, 2019 | August 31, 2025 | STAUFFER, WILLIAM RICHARD | reporter.nih.gov |
| Advanced Technology to Study Visual Function on a Cellular Scale | NIH | National Eye Institute | 2021 to 2023 | $3,119,323 | April 1, 2014 | June 30, 2025 | ROORDA, AUSTIN | reporter.nih.gov |
| Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina | NIH | National Institute on Aging | 2021 to 2025 | $3,113,565 | April 1, 2018 | June 30, 2028 | KORONYO-HAMAOUI, MAYA | reporter.nih.gov |
| Optically Induced Anisometropias | NIH | National Eye Institute | 2021 to 2025 | $3,111,021 | February 1, 1981 | May 31, 2027 | OSTRIN, LISA A | reporter.nih.gov |
| BP-BRAIN-ENDURE at Hunter and NYU | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,110,022 | September 30, 2010 | August 31, 2030 | SCHAFE, GLENN E | reporter.nih.gov |
| Integrative circuit dissection in the behaving nonhuman primate | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $3,101,478 | April 15, 2023 | March 31, 2027 | PASUPATHY, ANITHA | reporter.nih.gov |
| Biomechanical Analysis in Strabismus Surgery | NIH | National Eye Institute | 2021 to 2025 | $3,099,567 | January 6, 1991 | May 31, 2029 | DEMER, JOSEPH LOUIS | reporter.nih.gov |
| The Cerebro-Cerebellar-Basal-Gangliar Network for Visuomotor Learning | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $3,084,394 | August 1, 2019 | April 30, 2024 | GOLDBERG, MICHAEL E. | reporter.nih.gov |
| Diagnostic Innovations in Glaucoma Study (DIGS): Glaucoma and High Myopia | NIH | National Eye Institute | 2021 to 2025 | $3,060,191 | March 1, 2017 | August 31, 2027 | ZANGWILL, LINDA M | reporter.nih.gov |
| First Aid Medicine to Treat Vesicant Induced Corneal Injury | NIH | National Eye Institute | 2022 to 2025 | $3,055,554 | September 30, 2022 | August 31, 2027 | CHANDLER, HEATHER | reporter.nih.gov |
| Novel Glaucoma Diagnostics for Structure and Function. | NIH | National Eye Institute | 2023 to 2025 | $3,043,548 | August 1, 2000 | July 31, 2029 | SCHUMAN, JOEL S | reporter.nih.gov |
| Central cholinergic presbyvestibulopathy network changes and imbalance in Parkinson's disease and older persons | NIH | National Institute on Aging | 2021 to 2025 | $3,043,334 | September 30, 2021 | May 31, 2027 | BOHNEN, NICOLAAS IDA | reporter.nih.gov |
| Using Informatics to Evaluate and Predict Cataract Surgery Impact on Alzheimer's Disease and Related Dementias and Mild Cognitive Impairment Outcomes | NIH | National Institute on Aging | 2022 to 2025 | $3,042,048 | September 1, 2022 | May 31, 2027 | PERSHING, SUZANN | reporter.nih.gov |
| Control of cell proliferation and differentiation by growth pathways | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,036,731 | May 1, 2019 | April 30, 2029 | FROLOV, MAXIM | reporter.nih.gov |
| Retinal Circuitry | NIH | National Eye Institute | 2021 to 2025 | $3,035,626 | January 1, 2019 | March 31, 2030 | JONES, BRYAN WILLIAM | reporter.nih.gov |
| Development of an ophthalmic diagnostic probe for cerebral amyloid angiopathy in patients | NIH | National Institute on Aging | 2021 to 2022 | $3,033,670 | June 1, 2021 | May 31, 2024 | SARRAF, STELLA | reporter.nih.gov |
| Activity-Dependent Mechanisms of Memory Consolidation | NIH | National Eye Institute | 2021 to 2025 | $3,026,968 | January 1, 2021 | May 8, 2026 | RAYMOND, JENNIFER L | reporter.nih.gov |
| Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy | NIH | National Eye Institute | 2021 to 2022 | $3,026,491 | September 30, 2018 | August 31, 2024 | REX, TONIA S | reporter.nih.gov |
| Optimizing a Stapled-Peptide That Specifically Targets HSV-1 to Treat Herpes Ocular Keratitis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $3,015,759 | May 1, 2020 | May 31, 2026 | REITZ, ALLEN BERNARD | reporter.nih.gov |
| Blood outer retina barrier regulation | NIH | National Eye Institute | 2021 to 2025 | $3,014,680 | February 1, 2020 | May 31, 2030 | DEAN, DOUGLAS CHASE | reporter.nih.gov |
| Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care | NIH | National Eye Institute | 2021 to 2025 | $3,011,769 | March 10, 2016 | May 31, 2026 | TOTH, CYNTHIA ANN | reporter.nih.gov |
| Engineering multi-lineage inner ear organoids | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,010,274 | December 1, 2018 | June 30, 2025 | KOEHLER, KARL RUSSELL | reporter.nih.gov |
| Uncovering novel biological processes and pathogenic mechanisms for glaucoma | NIH | National Eye Institute | 2021 to 2024 | $3,009,870 | June 1, 2020 | May 31, 2026 | SEGRE, AYELLET VERED | reporter.nih.gov |
| Novel model systems for the study of cone disorders and other heritable retinal diseases | NIH | National Eye Institute | 2021 to 2023 | $3,008,070 | September 30, 2018 | August 31, 2024 | ROGERS, JEFFREY A. | reporter.nih.gov |
| A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES) | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,999,652 | September 25, 2023 | August 31, 2027 | NADIG, SATISH N | reporter.nih.gov |
| Pax6 as a key regulator of lens development | NIH | National Eye Institute | 2021 to 2025 | $2,996,871 | January 1, 2000 | May 31, 2026 | CVEKL, ALES | reporter.nih.gov |
| Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,992,236 | June 7, 2024 | May 31, 2026 | STEWART, CHARLES ANDREW | reporter.nih.gov |
| Development of Gene Replacement Therapy for Sanfilippo Syndrome Type C | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $2,990,505 | September 19, 2022 | August 31, 2025 | SINGAMSETTY, SRIKANTH | reporter.nih.gov |
| Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,977,682 | September 23, 2021 | August 31, 2024 | SARRAF, STELLA | reporter.nih.gov |
| Processing and transformation of visual signals in the superior colliculus | NIH | National Eye Institute | 2021 to 2025 | $2,977,065 | September 30, 2008 | April 30, 2027 | TAO, HUIZHONG WHIT | reporter.nih.gov |
| Integration and functionality of retinal organoid transplants | NIH | National Eye Institute | 2021 to 2025 | $2,971,351 | May 1, 2021 | March 31, 2027 | SEILER, MAGDALENE J | reporter.nih.gov |
| Functional and Structural Optical Coherence Tomography for Glaucoma | NIH | National Eye Institute | 2021 to 2025 | $2,959,392 | September 30, 2013 | May 31, 2026 | HUANG, DAVID | reporter.nih.gov |
| Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,957,132 | September 7, 2020 | August 31, 2025 | LESSARD, CHRISTOPHER J | reporter.nih.gov |
| Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard | NIH | National Eye Institute | 2021 to 2024 | $2,948,924 | August 1, 2020 | July 31, 2025 | MOHAN, RAJIV RAVINDRA | reporter.nih.gov |
| Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children (MAGIC) Study | NIH | National Eye Institute | 2021 to 2024 | $2,946,040 | May 1, 2021 | April 30, 2026 | LUPO, PHILIP | reporter.nih.gov |
| Scanning and Detection at Intersections | NIH | National Eye Institute | 2021 to 2024 | $2,936,935 | September 30, 2015 | August 31, 2025 | BOWERS, ALEXANDRA RAE | reporter.nih.gov |
| Tear protein biomarkers of refractive surgery pain | NIH | National Eye Institute | 2023 to 2025 | $2,933,372 | September 1, 2020 | February 28, 2027 | AICHER, SUE A | reporter.nih.gov |
| "A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways" | NIH | National Institute on Aging | 2021 to 2023 | $2,920,747 | March 1, 2019 | December 31, 2024 | KAUFMAN, RANDAL J. | reporter.nih.gov |
| Mechanisms of RPE dysfunction in macular degenerations: role of intracellular complement activation | NIH | National Eye Institute | 2021 to 2024 | $2,920,740 | May 1, 2020 | April 30, 2025 | LAKKARAJU, APARNA | reporter.nih.gov |
| A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2025 | $2,920,229 | May 1, 2021 | July 31, 2027 | BHUIYAN, ALAUDDIN | reporter.nih.gov |
| A Novel Probiotic for the Treatment of Sjogren's Syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $2,918,422 | May 12, 2021 | April 30, 2026 | FANGER, GARY | reporter.nih.gov |
| Neural basis of Braille literacy in blind adults and children | NIH | National Eye Institute | 2022 to 2025 | $2,913,770 | March 1, 2022 | February 28, 2027 | BEDNY, MARINA | reporter.nih.gov |
| Retinal disease models for translational photoreceptor replacement | NIH | National Eye Institute | 2021 to 2022 | $2,898,123 | September 30, 2018 | May 31, 2025 | WOLFE, JOHN H | reporter.nih.gov |
| Genomic Sequencing of Japanese Macaques to Enhance NHP Model Discovery | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $2,892,711 | July 1, 2016 | June 30, 2025 | FERGUSON, BETSY M | reporter.nih.gov |
| Functional Mechanism of Neural Control in Post-Concussion Convergence Insufficiency | NIH | National Eye Institute | 2021 to 2025 | $2,883,808 | April 1, 2014 | August 31, 2026 | ALVAREZ, TARA LYNN | reporter.nih.gov |
| The Pathogenesis of RNA Splicing Factor Associated Retinal Degeneration | NIH | National Eye Institute | 2021 to 2024 | $2,874,308 | April 1, 2011 | March 31, 2026 | PIERCE, ERIC A | reporter.nih.gov |
| Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance | NIH | National Cancer Institute | 2021 to 2025 | $2,873,427 | June 1, 2021 | May 31, 2027 | MARTINEZ-CONDE, SUSANA | reporter.nih.gov |
| Defining early-onset glaucomagenetic etiologies | NIH | National Eye Institute | 2021 to 2024 | $2,873,221 | September 1, 2020 | June 30, 2026 | WIGGS, JANEY L | reporter.nih.gov |
| Characterization of purified myocilin: glaucoma as a protein misfolding disease | NIH | National Eye Institute | 2021 to 2025 | $2,869,357 | March 1, 2011 | February 28, 2027 | LIEBERMAN, RAQUEL L | reporter.nih.gov |
| Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $2,866,312 | August 17, 2023 | July 31, 2028 | IZMIRLY, PETER | reporter.nih.gov |
| The role of area V4 in the perception and recognition of visual objects | NIH | National Eye Institute | 2021 to 2025 | $2,859,713 | April 1, 2009 | April 30, 2029 | PASUPATHY, ANITHA | reporter.nih.gov |
| Neural Mechanisms of Reading Dysfunction in Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2024 | $2,859,710 | July 1, 2020 | April 23, 2025 | JAVITT, DANIEL C. | reporter.nih.gov |
| Infants' self-generated visual statistics support object and category learning | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,858,600 | September 21, 2021 | July 31, 2026 | SMITH, LINDA B. | reporter.nih.gov |
| Functional maturation of interneurons that mediate the vestibulo-ocular reflex - Renewal - Resubmission - 1 | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,853,300 | December 1, 2018 | November 30, 2029 | SCHOPPIK, DAVID | reporter.nih.gov |
| Visual Field Expansion Through Innovative Multi-periscopic Prism Design (AD) | NIH | National Eye Institute | 2021 to 2024 | $2,852,054 | September 1, 2024 | August 31, 2025 | PELI, ELI | reporter.nih.gov |
| Recognition of Cellular Targets by single and double-stranded nucleic acids | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,839,825 | April 1, 2016 | May 7, 2026 | COREY, DAVID R | reporter.nih.gov |
| Structure-function studies of visual arrestin | NIH | National Eye Institute | 2021 to 2025 | $2,835,886 | April 1, 1997 | April 30, 2028 | GUREVICH, VSEVOLOD V. | reporter.nih.gov |
| Retinal Iron Health in Transport and Disease | NIH | National Eye Institute | 2021 to 2025 | $2,835,594 | August 1, 2004 | April 30, 2028 | DUNAIEF, JOSHUA L | reporter.nih.gov |
| Cortical visual processing for navigation | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,833,387 | April 15, 2021 | March 31, 2024 | SMITH, SPENCER LAVERE | reporter.nih.gov |
| Translational Research for Retinal Degeneration Therapies | NIH | National Eye Institute | 2021 to 2024 | $2,827,259 | September 30, 2007 | August 31, 2025 | BELTRAN, WILLIAM A. | reporter.nih.gov |
| Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research | NIH | National Eye Institute | 2021 to 2022 | $2,820,106 | September 30, 2018 | August 31, 2022 | CARROLL, JOSEPH | reporter.nih.gov |
| Cortical Mechanisms of Visual Category Recognition and Learning | NIH | National Eye Institute | 2021 to 2025 | $2,810,719 | September 1, 2009 | June 30, 2028 | FREEDMAN, DAVID J | reporter.nih.gov |
| High Resolution Mapping of Foveal Ganglion Cell Receptive Fields in the Living Primate Eye | NIH | National Eye Institute | 2021 to 2025 | $2,806,850 | January 1, 2021 | November 30, 2025 | WILLIAMS, DAVID R | reporter.nih.gov |
| Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus | NIH | National Eye Institute | 2022 to 2023 | $2,806,822 | September 30, 2016 | July 31, 2023 | COHEN, ELISABETH J | reporter.nih.gov |
| Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $2,806,464 | July 1, 2021 | August 31, 2027 | CHIARAMELLO, ANNE ELIANE | reporter.nih.gov |
| Computational foundations of active visual sensing | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,804,597 | March 15, 2022 | March 31, 2024 | TOLIAS, ANDREAS | reporter.nih.gov |
| Bi-directional neural interface for probing parallel visual pathways | NIH | National Eye Institute | 2021 to 2024 | $2,782,532 | September 1, 2021 | May 31, 2026 | CHICHILNISKY, EDUARDO | reporter.nih.gov |
| Intracellular Calcium in Hair Cells | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,777,983 | January 1, 1992 | February 28, 2029 | FETTIPLACE, ROBERT | reporter.nih.gov |
| Modulation of the Vestibular System Using Prosthetic Direct Current Stimulation | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,774,450 | March 1, 2021 | February 28, 2027 | FRIDMAN, GENE YEVGENY | reporter.nih.gov |
| UCSF-Proctor Clinician Vision Scholars K12 Program | NIH | National Eye Institute | 2021 to 2025 | $2,766,111 | May 1, 2020 | August 31, 2030 | OU, YVONNE | reporter.nih.gov |
| Retinal-adhesive thermoresponsive gel for AAV-mediated gene delivery to the outer retina | NIH | National Eye Institute | 2022 to 2025 | $2,749,546 | September 30, 2022 | July 31, 2027 | SAHEL, JOSE-ALAIN | reporter.nih.gov |
| Vision recovery in cortical blindness | NIH | National Eye Institute | 2021 to 2025 | $2,738,966 | February 1, 2017 | January 31, 2027 | HUXLIN, KRYSTEL R | reporter.nih.gov |
| Mechanism of photoreceptor cell degeneration in animal models of retinal diseases | NIH | National Eye Institute | 2021 to 2025 | $2,732,853 | August 1, 1995 | February 28, 2030 | NAASH, MUNA I. | reporter.nih.gov |
| Nlrp3 inflammasome activation in early diabetic retinopathy | NIH | National Eye Institute | 2021 to 2024 | $2,726,569 | September 1, 2020 | May 31, 2025 | AMBATI, JAYAKRISHNA | reporter.nih.gov |
| Enhanced Identification of Ocular Phenotypes and Outcomes in Electronic Health Record Data | NIH | National Eye Institute | 2022 to 2025 | $2,723,478 | June 1, 2022 | June 30, 2026 | STEIN, JOSHUA D | reporter.nih.gov |
| Disability, diversity and trust in precision medicine research: stakeholdersengagement | NIH | National Human Genome Research Institute | 2021 to 2023 | $2,700,154 | March 12, 2021 | March 13, 2025 | SABATELLO, MAYA | reporter.nih.gov |
| Systems-Level and in Situ Transcriptomics Deconstruction of Neural Circuits Underlying Sensorimotor Transformation in an Innate Behavior | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $2,697,525 | April 1, 2020 | March 31, 2026 | DULAC, CATHERINE | reporter.nih.gov |
| The Impact of the Herpes Zoster Vaccine on Herpes Zoster Ophthalmicus | NIH | National Eye Institute | 2021 to 2025 | $2,694,319 | January 1, 2018 | May 31, 2028 | ACHARYA, NISHA | reporter.nih.gov |
| Translational control by nutrients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,682,102 | March 15, 2002 | April 30, 2027 | HATZOGLOU, MARIA | reporter.nih.gov |
| Mechanisms of photoreceptor protein transport and compartmentalization | NIH | National Eye Institute | 2021 to 2025 | $2,678,876 | September 1, 2007 | November 30, 2025 | CALVERT, PETER DEANE | reporter.nih.gov |
| Interpericyte tunneling nanotubes as new therapeutic targets for neurovascular recovery and vision restoration in glaucoma. | NIH | National Eye Institute | 2025 | $2,674,763 | September 30, 2025 | September 29, 2028 | DI POLO, ADRIANA | reporter.nih.gov |
| Optical Coherence Elastography of the Cornea | NIH | National Eye Institute | 2021 to 2025 | $2,674,668 | June 1, 2012 | May 31, 2029 | LARIN, KIRILL V | reporter.nih.gov |
| Gating of Firing Rate Homeostasis by Sleep and Wake States During Experience-Dependent Plasticity | NIH | National Eye Institute | 2021 to 2025 | $2,673,241 | September 1, 2017 | April 30, 2027 | TURRIGIANO, GINA G | reporter.nih.gov |
| Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography | NIH | National Eye Institute | 2021 to 2024 | $2,672,949 | May 1, 2018 | April 30, 2026 | WEINREB, ROBERT N | reporter.nih.gov |
| Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis | NIH | National Eye Institute | 2021 to 2025 | $2,667,355 | December 1, 1984 | August 31, 2027 | CIOLINO, JOSEPH B. | reporter.nih.gov |
| Development of 3D-FAST Optical Interface for Rapid Volumetric Neural Sensing and Modulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,665,761 | September 1, 2021 | June 30, 2025 | GIBSON, EMILY | reporter.nih.gov |
| Structure and function of primate retinal circuits | NIH | National Eye Institute | 2021 to 2025 | $2,661,662 | April 1, 2014 | August 31, 2028 | PUTHUSSERY, TERESA | reporter.nih.gov |
| Functionally Validated Structural Endpoints for Early AMD | NIH | National Eye Institute | 2021 to 2023 | $2,660,293 | May 1, 2019 | February 28, 2026 | OWSLEY, CYNTHIA | reporter.nih.gov |
| Molecular mechanisms of corneal recurrent erosion formation | NIH | National Eye Institute | 2021 to 2024 | $2,660,044 | July 1, 1992 | July 31, 2026 | STEPP, MARY ANN | reporter.nih.gov |
| Plasticity of the Retinogeniculate Synapse | NIH | National Eye Institute | 2021 to 2025 | $2,659,059 | September 1, 2003 | May 31, 2030 | CHEN, CHINFEI | reporter.nih.gov |
| Elucidating novel mechanisms for glucocorticoid-induced ocular hypertension | NIH | National Eye Institute | 2021 to 2024 | $2,655,713 | January 1, 2020 | December 31, 2025 | SOBRIN, LUCIA | reporter.nih.gov |
| Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma | NIH | National Cancer Institute | 2021 to 2025 | $2,651,883 | April 1, 2021 | March 31, 2026 | GUTKIND, JORGE SILVIO | reporter.nih.gov |
| Biomechanical mapping of the optic nerve head and peripapillary sclera using high frequency ultrasonic elastography | NIH | National Eye Institute | 2021 to 2024 | $2,628,729 | March 1, 2021 | November 30, 2025 | ZHOU, QIFA | reporter.nih.gov |
| Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,623,751 | September 30, 2016 | July 31, 2023 | WANG, DANNY JJ | reporter.nih.gov |
| Excitation and Inhibition in Neural Circuits of the Visual Cortex | NIH | National Eye Institute | 2021 to 2025 | $2,623,384 | September 1, 2013 | May 31, 2029 | ADESNIK, HILLEL | reporter.nih.gov |
| Molecular mechanisms underlying strabismus risk | NIH | National Eye Institute | 2022 to 2025 | $2,621,285 | January 1, 2022 | December 31, 2026 | WHITMAN, MARY CATHERINE | reporter.nih.gov |
| Binocular Coordination of Eye Movements | NIH | National Eye Institute | 2021 to 2025 | $2,618,216 | April 1, 2016 | April 30, 2029 | DAS, VALLABH E | reporter.nih.gov |
| Neuroscience Training Program at Washington University | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,606,948 | July 1, 2021 | June 30, 2026 | KERSCHENSTEINER, DANIEL | reporter.nih.gov |
| Development of Gene Therapy for Hereditary Deafness using Rational Protein Engineering | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $2,600,046 | June 17, 2022 | May 31, 2027 | INDZHYKULIAN, ARTUR | reporter.nih.gov |
| Function of Fixational Instability During Natural Viewing | NIH | National Eye Institute | 2021 to 2025 | $2,590,406 | September 1, 2007 | July 31, 2027 | RUCCI, MICHELE | reporter.nih.gov |
| Neural Mechanisms for Feature-Based Attention | NIH | National Eye Institute | 2021 to 2025 | $2,590,302 | January 1, 2019 | December 31, 2028 | DESIMONE, ROBERT | reporter.nih.gov |
| miR-92a as a biomarker of diabetic retinopathy | NIH | National Eye Institute | 2021 to 2025 | $2,587,856 | September 30, 2021 | July 31, 2027 | BHATWADEKAR, ASHAY D | reporter.nih.gov |
| Development of an IOP-lowering gene therapy treatment for glaucoma | NIH | National Eye Institute | 2022 to 2025 | $2,587,720 | June 1, 2022 | May 31, 2027 | LIPINSKI, DANIEL MARK | reporter.nih.gov |
| Spatial and nonspatial knowledge | NIH | National Eye Institute | 2021 to 2025 | $2,576,690 | February 1, 2021 | January 31, 2027 | EPSTEIN, RUSSELL A | reporter.nih.gov |
| Cortical mechanisms mediating visual function and behavior | NIH | National Eye Institute | 2021 to 2025 | $2,576,261 | August 1, 2014 | July 31, 2026 | SEIDEMANN, EYAL J | reporter.nih.gov |
| The Statistics of Infant First-Person Visual Experience | NIH | National Eye Institute | 2021 to 2025 | $2,575,605 | September 30, 2021 | July 31, 2027 | SMITH, LINDA B. | reporter.nih.gov |
| Enhancement, mapping, and validation of viral vectors for primate optogenetics | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,571,104 | January 15, 2022 | December 31, 2026 | SOMMER, MARC A | reporter.nih.gov |
| Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations | NIH | National Eye Institute | 2021 to 2023 | $2,570,468 | March 1, 2019 | December 31, 2025 | PORCIATTI, VITTORIO | reporter.nih.gov |
| Regulatory role of PI3K signaling pathways in lens differentiation and function | NIH | National Eye Institute | 2021 to 2025 | $2,568,508 | December 1, 2015 | April 30, 2030 | MENKO, A. SUE | reporter.nih.gov |
| Micro-TeACH (Microbiome Technology and Analytic Center Hub) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,568,320 | March 10, 2022 | December 31, 2026 | SCHER, JOSE U. | reporter.nih.gov |
| Revealing the mechanisms of primate face recognition with synthetic stimulus sets optimized to compare computational models | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,568,097 | July 15, 2022 | June 30, 2025 | KRIEGESKORTE, NIKOLAUS | reporter.nih.gov |
| Circuit Mechanisms Underlying Persistent Activity in a Neural Integrator | NIH | National Eye Institute | 2022 to 2025 | $2,566,168 | August 1, 2016 | July 31, 2027 | AKSAY, EMRE R | reporter.nih.gov |
| Dietary control of angiogenesis in retinopathy models | NIH | National Eye Institute | 2021 to 2025 | $2,563,997 | July 1, 2006 | June 30, 2027 | SMITH, LOIS | reporter.nih.gov |
| Clarifying the Optimal Application of SLT Therapy (COAST) | NIH | National Eye Institute | 2021 to 2024 | $2,555,552 | September 30, 2020 | August 31, 2025 | REALINI, ANTHONY | reporter.nih.gov |
| Imaging immune cell type and behavior in the living retina using adaptive optics | NIH | National Eye Institute | 2021 to 2025 | $2,552,420 | September 30, 2017 | August 31, 2027 | SCHALLEK, JESSE BARRETT | reporter.nih.gov |
| Naturalistic electrical stimulation strategies for effective visual cortical prostheses | NIH | National Eye Institute | 2021 to 2025 | $2,549,794 | September 1, 2013 | February 28, 2028 | YOSHOR, DANIEL | reporter.nih.gov |
| Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2024 | $2,549,156 | September 30, 2020 | September 29, 2025 | STERN, JEFFREY H | reporter.nih.gov |
| Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model | NIH | National Eye Institute | 2021 to 2025 | $2,545,050 | January 1, 2021 | November 30, 2025 | ULLIAN, ERIK M | reporter.nih.gov |
| Michigan Vision Clinician Scientist Development Program | NIH | National Eye Institute | 2021 to 2025 | $2,543,070 | May 15, 2013 | June 30, 2028 | ZACKS, DAVID N | reporter.nih.gov |
| Defining mechanisms for natural vision in the primate brain with machine learning | NIH | National Eye Institute | 2022 to 2025 | $2,542,500 | September 30, 2022 | July 31, 2027 | PONCE, CARLOS RAMON | reporter.nih.gov |
| Sleep and Circadian Regulation in Diabetic Retinopathy: The Role of Intrinsically Photosensitive Retinal Ganglion Cells and Melatonin Supplementation | NIH | National Eye Institute | 2021 to 2024 | $2,534,775 | September 1, 2020 | August 31, 2025 | REUTRAKUL, SIRIMON | reporter.nih.gov |
| Peripheral vestibular hypofunction and neurosensory coding | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,534,390 | May 1, 2021 | April 30, 2027 | HOFFMAN, LARRY F | reporter.nih.gov |
| Linking retinal circuits to perception | NIH | National Eye Institute | 2021 to 2025 | $2,531,397 | February 1, 2018 | May 31, 2027 | NEITZ, JAY | reporter.nih.gov |
| Immunopathogenic Mechanisms of Dry Eye Disease | NIH | National Eye Institute | 2021 to 2025 | $2,528,012 | September 30, 2010 | November 30, 2029 | DANA, REZA | reporter.nih.gov |
| Molecular Genetics of Age-Dependent Retinal Degeneration | NIH | National Eye Institute | 2021 to 2025 | $2,527,132 | August 1, 2012 | July 31, 2028 | IKEDA, AKIHIRO | reporter.nih.gov |
| Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration | NIH | National Eye Institute | 2022 to 2025 | $2,526,222 | April 1, 2018 | June 30, 2026 | FERRINGTON, DEBORAH ANN | reporter.nih.gov |
| Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,522,214 | April 1, 2016 | June 30, 2026 | BISCHOFF, JOYCE E. | reporter.nih.gov |
| OCT Angiography for Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2025 | $2,521,643 | September 1, 2014 | May 31, 2027 | JIA, YALI | reporter.nih.gov |
| Sanitation, Water, and Instruction in face-washing for trachoma II (SWIFT II) | NIH | National Eye Institute | 2021 to 2023 | $2,519,881 | September 30, 2014 | August 31, 2025 | KEENAN, JEREMY DAVID | reporter.nih.gov |
| Developing gene editing platforms for retinal degeneration. | NIH | National Eye Institute | 2022 to 2025 | $2,519,176 | September 30, 2022 | June 30, 2027 | SAHAY, GAURAV | reporter.nih.gov |
| Neuronal Regulation of Low-Grade Gliomagenesis | NIH | National Cancer Institute | 2022 to 2025 | $2,518,768 | April 1, 2022 | March 31, 2027 | MONJE-DEISSEROTH, MICHELLE | reporter.nih.gov |
| Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy | NIH | National Eye Institute | 2021 to 2025 | $2,513,809 | July 1, 2010 | July 31, 2029 | JURKUNAS, ULA V. | reporter.nih.gov |
| Membrane Protein Effectors of Pathogen Interactions With Host | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,510,135 | June 1, 2016 | May 31, 2026 | MARASSI, FRANCESCA M | reporter.nih.gov |
| Usher Proteins in the Inner ear Structure and Function | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,508,459 | December 1, 2012 | November 30, 2028 | AHMED, ZUBAIR M. | reporter.nih.gov |
| Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration | NIH | National Eye Institute | 2021 to 2025 | $2,501,531 | August 1, 2020 | August 31, 2029 | SABAN, DANIEL RAPHAEL | reporter.nih.gov |
| The Genetics of Ocular Melanoma | NIH | National Cancer Institute | 2021 to 2024 | $2,499,142 | July 1, 2011 | February 28, 2026 | BOWCOCK, ANNE MARY | reporter.nih.gov |
| FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy. | NIH | National Eye Institute | 2021 to 2024 | $2,497,198 | April 1, 2017 | March 31, 2026 | ANAND-APTE, BELA | reporter.nih.gov |
| Dynamic Multi-Coil B0 Shimming for Diagnostic MRI of Frontal Brain | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,494,835 | April 7, 2021 | December 31, 2025 | VAUGHAN, JOHN T | reporter.nih.gov |
| Development of standardized resources for characterization of the resident ocular surface microbiome. | NIH | National Eye Institute | 2023 to 2025 | $2,493,155 | July 1, 2023 | June 30, 2027 | ENSIGN, LAURA | reporter.nih.gov |
| Dopamine Mediated Control of Retinal Vascular Integrity | NIH | National Eye Institute | 2022 to 2025 | $2,491,576 | September 30, 2022 | June 30, 2027 | SAMUEL, MELANIE A | reporter.nih.gov |
| Limbic-midbrain interactions in defense and emotional arousal | NIH | National Institute of Mental Health | 2021 to 2024 | $2,485,160 | February 3, 2020 | November 30, 2025 | MALKOVA, LUDISE | reporter.nih.gov |
| Steroids and Cross-linking for Ulcer Treatment (SCUT II) | NIH | National Eye Institute | 2021 to 2023 | $2,483,620 | August 1, 2019 | January 31, 2026 | LIETMAN, THOMAS M | reporter.nih.gov |
| The role of Wnt signaling in treating glucocorticoid-induced glaucoma | NIH | National Eye Institute | 2021 to 2025 | $2,480,777 | September 30, 2021 | July 31, 2027 | MAO, WEIMING | reporter.nih.gov |
| PENN Vision Clinical Scientist Program | NIH | National Eye Institute | 2021 to 2025 | $2,480,765 | May 1, 2004 | May 31, 2026 | DUNAIEF, JOSHUA L | reporter.nih.gov |
| Imaging Neurodegeneration in Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,478,045 | April 1, 2013 | June 30, 2029 | SAIDHA, SHIV | reporter.nih.gov |
| Acquisition, extinction, and recall of attention biases to threat: Computational modeling and multimodal brain imaging | NIH | National Institute of Mental Health | 2021 to 2025 | $2,474,689 | August 1, 2021 | May 31, 2027 | DING, MINGZHOU | reporter.nih.gov |
| Plasticizing the cortex to enhance stroke recovery | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,473,526 | May 1, 2023 | April 30, 2026 | LEE, JIN-MOO | reporter.nih.gov |
| A new molecular therapy against ocular herpes | NIH | National Eye Institute | 2021 to 2025 | $2,467,835 | August 1, 2015 | April 30, 2028 | SHUKLA, DEEPAK | reporter.nih.gov |
| Motor, Visual, and Olfactory Changes in Genetic Subtypes of Alzheimer’s Disease | NIH | National Institute on Aging | 2021 to 2023 | $2,462,259 | February 15, 2019 | November 30, 2024 | RINGMAN, JOHN M | reporter.nih.gov |
| Mechanisms of Blast-Induced Vestibular Injury | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,459,906 | September 11, 2020 | August 31, 2025 | ZHU, HONG | reporter.nih.gov |
| Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and Surgery | NIH | National Eye Institute | 2022 to 2025 | $2,454,968 | July 1, 2022 | June 30, 2027 | DUPPS, WILLIAM JOSEPH | reporter.nih.gov |
| Fas Ligand Cleavage regulates ocular homeostasis and glaucoma | NIH | National Eye Institute | 2022 to 2025 | $2,452,230 | February 1, 2022 | January 31, 2027 | GREGORY-KSANDER, MEREDITH | reporter.nih.gov |
| Hermansky-Pudlak syndrome and melanosome formation | NIH | National Eye Institute | 2022 to 2025 | $2,448,434 | May 1, 2004 | June 30, 2027 | MARKS, MICHAEL S | reporter.nih.gov |
| The Ohio State University Vision Sciences Research Core Program (OSU-VSRCP) | NIH | National Eye Institute | 2022 to 2025 | $2,447,794 | September 30, 2022 | June 30, 2027 | MOROI, SAYOKO E | reporter.nih.gov |
| Behavioral Consequences and cellular substrates of plasticity in visual cortex | NIH | National Eye Institute | 2022 to 2025 | $2,447,720 | August 1, 2013 | April 30, 2027 | BEAR, MARK F | reporter.nih.gov |
| Genetic Modifiers of Retinal Disease | NIH | National Eye Institute | 2022 to 2025 | $2,439,084 | March 1, 2022 | February 28, 2027 | NISHINA, PATSY M | reporter.nih.gov |
| Contribution of Mast Cells in Non-Allergic Ocular Inflammation | NIH | National Eye Institute | 2021 to 2025 | $2,432,950 | September 1, 2019 | May 31, 2027 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Multi-sensory representations for navigation in the central brain of Drosophila | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,426,196 | July 1, 2019 | June 30, 2029 | NAGEL, KATHERINE | reporter.nih.gov |
| Increasing the isoplanatic patch in adaptive optics ophthalmoscopy | NIH | National Eye Institute | 2021 to 2025 | $2,425,489 | June 1, 2021 | March 31, 2027 | DUBRA, ALFREDO | reporter.nih.gov |
| Connecting AMD SNPs to Functions Using Allele-specific Interactions | NIH | National Eye Institute | 2021 to 2025 | $2,425,296 | January 1, 2021 | November 30, 2026 | ZACK, DONALD J. | reporter.nih.gov |
| Lacritin Regulation of Homeostasis and Ocular Surface Health | NIH | National Eye Institute | 2021 to 2025 | $2,424,560 | September 1, 2021 | July 31, 2026 | LAURIE, GORDON WILLIAM | reporter.nih.gov |
| Modulators for Retinal Ganglion Cell Injury | NIH | National Eye Institute | 2021 to 2025 | $2,422,703 | March 1, 2021 | February 28, 2027 | GEISERT, ELDON E | reporter.nih.gov |
| Downstream Actions of Biophysical Mechanisms in the Visual System | NIH | National Eye Institute | 2022 to 2025 | $2,416,832 | September 1, 2022 | June 30, 2027 | DO, MICHAEL TRI HOANG | reporter.nih.gov |
| Olfactory modulation of color vision and behavior in mosquitoes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,412,809 | February 16, 2023 | January 31, 2028 | RIFFELL, JEFFREY A | reporter.nih.gov |
| Redox-sensitive activation of REDD1 in diabetic retinopathy | NIH | National Eye Institute | 2021 to 2025 | $2,408,855 | September 30, 2021 | July 31, 2028 | DENNIS, MICHAEL D | reporter.nih.gov |
| Applications of high resolution fMRI in ultra-high field (7T) in revealing developmental disorders underlying amblyopia | NIH | National Eye Institute | 2021 to 2024 | $2,407,891 | April 1, 2020 | March 31, 2026 | NASR, SHAHIN | reporter.nih.gov |
| UV to blue neuronal phototransduction mechanisms | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,402,747 | April 1, 2018 | March 31, 2028 | HOLMES, TODD C | reporter.nih.gov |
| Retinal circuit disassembly in primate glaucoma | NIH | National Eye Institute | 2023 to 2025 | $2,400,691 | July 1, 2023 | April 30, 2028 | OU, YVONNE | reporter.nih.gov |
| Slit2-ROBO signaling in pericytes and myeloid cells controls vascular development and ocular neovascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,400,609 | July 1, 2015 | January 31, 2026 | EICHMANN, ANNE CHRISTINE | reporter.nih.gov |
| Anatomical and functional organization of inter-areal feedback circuits in the visual cortex, and their impact on neuronal responses | NIH | National Eye Institute | 2021 to 2025 | $2,400,166 | June 1, 2016 | May 31, 2027 | ANGELUCCI, ALESSANDRA | reporter.nih.gov |
| Epidemiology of Biomarkers of AMD Progression | NIH | National Eye Institute | 2021 to 2025 | $2,396,992 | September 30, 2021 | August 31, 2027 | SADDA, SRINIVAS R | reporter.nih.gov |
| Visual Cortex as a Window to Microstructural and Functional Development of the Human Brain | NIH | National Eye Institute | 2022 to 2025 | $2,393,471 | May 1, 2022 | April 30, 2027 | GRILL-SPECTOR, KALANIT | reporter.nih.gov |
| Neural Retina-Specific Bim Expression and Hyperoxia Sensitivity of the Developing Retinal Vasculature | NIH | National Eye Institute | 2021 to 2025 | $2,391,108 | September 30, 2021 | July 31, 2027 | ZAITOUN, ISMAIL S | reporter.nih.gov |
| Regulation of the intrinsic melanopsin-based light response in ipRGCs | NIH | National Eye Institute | 2022 to 2025 | $2,390,601 | May 1, 2017 | April 30, 2027 | ROBINSON, PHYLLIS R | reporter.nih.gov |
| The complex role of phosphodiesterase 6 in rod photoreceptor health and function | NIH | National Eye Institute | 2021 to 2025 | $2,374,650 | September 1, 2020 | March 31, 2030 | PALCZEWSKI, KRZYSZTOF | reporter.nih.gov |
| The Physiology of Vestibular Compensation | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,373,856 | September 1, 1995 | June 30, 2029 | CULLEN, KATHLEEN E | reporter.nih.gov |
| CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases | NIH | National Eye Institute | 2022 to 2025 | $2,373,472 | June 1, 2022 | May 31, 2027 | LIU, QIN | reporter.nih.gov |
| Tear Protein Microbial Regulation | NIH | National Eye Institute | 2021 to 2025 | $2,370,048 | September 30, 2016 | April 30, 2026 | LAURIE, GORDON WILLIAM | reporter.nih.gov |
| Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma | NIH | National Eye Institute | 2021 to 2024 | $2,366,638 | May 1, 2016 | June 30, 2026 | QUAGGIN, SUSAN E. | reporter.nih.gov |
| Quantifying and Understanding Glaucoma Eye Drop Medication Instillation and Adherence | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,365,817 | July 1, 2022 | March 31, 2026 | NEWMAN-CASEY, PAULA ANNE | reporter.nih.gov |
| Biomechanics of accommodation | NIH | National Eye Institute | 2021 to 2024 | $2,363,997 | September 30, 2020 | June 30, 2026 | LARIN, KIRILL V | reporter.nih.gov |
| Mechanisms and Role of Spontaneous Retinal Waves in Visual Development. | NIH | National Eye Institute | 2022 to 2025 | $2,362,500 | August 1, 2005 | December 31, 2026 | CRAIR, MICHAEL C. | reporter.nih.gov |
| G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature. | NIH | National Eye Institute | 2021 to 2025 | $2,362,458 | May 1, 2021 | March 31, 2027 | HLA, TIMOTHY TUN | reporter.nih.gov |
| Unique physiological properties of novel ganglion cell types in primate retina | NIH | National Eye Institute | 2021 to 2025 | $2,361,941 | September 30, 2018 | February 28, 2027 | CHICHILNISKY, EDUARDO | reporter.nih.gov |
| Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2025 | $2,361,511 | March 1, 2020 | July 31, 2030 | HUSAIN, DEEBA | reporter.nih.gov |
| STRA6 and Ocular Vitamin A Homeostasis | NIH | National Eye Institute | 2021 to 2025 | $2,359,309 | August 1, 2018 | August 31, 2027 | VON LINTIG, JOHANNES FRIEDRICH | reporter.nih.gov |
| T Cell Regulation of Low-Grade Glioma | NIH | National Cancer Institute | 2022 to 2025 | $2,353,237 | September 9, 2022 | August 31, 2027 | GUTMANN, DAVID H | reporter.nih.gov |
| Multipotent ABCB5-positive cell therapeutics for corneal disease | NIH | National Eye Institute | 2021 to 2022 | $2,352,662 | April 1, 2018 | January 31, 2024 | FRANK, NATASHA Y | reporter.nih.gov |
| Vsx2 Dependent Regulation of Retinal Progenitor Cell Properties | NIH | National Eye Institute | 2021 to 2024 | $2,351,133 | August 1, 2003 | July 31, 2025 | LEVINE, EDWARD M | reporter.nih.gov |
| Protein-polymer nanomedicine for Sjogren's Syndrome | NIH | National Eye Institute | 2021 to 2025 | $2,348,434 | March 1, 2017 | May 31, 2025 | HAMM-ALVAREZ, SARAH F | reporter.nih.gov |
| Saccade Target Selection in Naturalistic Visual Search | NIH | National Eye Institute | 2021 to 2025 | $2,347,022 | September 1, 2019 | June 30, 2030 | MCPEEK, ROBERT M | reporter.nih.gov |
| Mechanisms of Neurotransmission in Vertebrate Retina | NIH | National Eye Institute | 2021 to 2025 | $2,345,413 | May 1, 1998 | February 28, 2027 | HEIDELBERGER, RUTH | reporter.nih.gov |
| Eph-ephrin signaling in the lens | NIH | National Eye Institute | 2021 to 2025 | $2,342,445 | March 1, 2021 | February 28, 2027 | CHENG, CATHERINE KEHSIN | reporter.nih.gov |
| Nonhuman Primate Model of Inherited Photoreceptor Degeneration | NIH | National Eye Institute | 2023 to 2025 | $2,341,778 | September 30, 2023 | March 31, 2027 | MCGILL, TREVOR JACKSON | reporter.nih.gov |
| Retinal sheet transplant impact on functional organization of visual cortex in retinal degenerate animal models | NIH | National Eye Institute | 2022 to 2025 | $2,340,862 | May 1, 2022 | March 31, 2027 | LYON, DAVID C | reporter.nih.gov |
| Characterization of Multiple Factors in Training and Plasticity in Central Vision Loss | NIH | National Eye Institute | 2021 to 2024 | $2,340,705 | March 1, 2021 | February 28, 2026 | VISSCHER, KRISTINA | reporter.nih.gov |
| Models, mechanisms and treatment of LMX1B-induced glaucoma | NIH | National Eye Institute | 2021 to 2024 | $2,340,033 | July 1, 2021 | April 30, 2025 | JOHN, SIMON W | reporter.nih.gov |
| Afferent and Efferent Visual Systems During Abnormal Vision Development | NIH | National Eye Institute | 2021 to 2024 | $2,333,562 | April 1, 2020 | December 31, 2025 | ROBERTS, TAWNA | reporter.nih.gov |
| Molecular mechanisms underlying direction-selective circuit assembly and function in the mouse visual system | NIH | National Eye Institute | 2021 to 2025 | $2,329,148 | September 1, 2021 | July 31, 2027 | KOLODKIN, ALEX L | reporter.nih.gov |
| Dynamics of calcium signals control neurotransmitter release in retinal ribbon synapses | NIH | National Eye Institute | 2021 to 2025 | $2,328,731 | January 1, 2021 | December 31, 2026 | VAITHIANATHAN, THIRUMALINI | reporter.nih.gov |
| ABCB5-positive stem cells for LSCD therapy | NIH | National Eye Institute | 2023 to 2025 | $2,325,074 | June 1, 2016 | May 31, 2028 | FRANK, MARKUS H. | reporter.nih.gov |
| IOP and Cerebrospinal Fluid Pressure-related Risk Factors for Glaucoma | NIH | National Eye Institute | 2022 to 2025 | $2,320,577 | December 1, 2015 | May 31, 2027 | DOWNS, J CRAWFORD | reporter.nih.gov |
| Clinical Testing of an Intracortical Visual Prosthesis System | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,320,306 | September 30, 2016 | May 31, 2027 | TROYK, PHILIP R | reporter.nih.gov |
| No-Touch High Resolution Optical Coherence Elastography of the Cornea using a Heartbeat | NIH | National Eye Institute | 2022 to 2025 | $2,316,257 | September 30, 2022 | July 31, 2027 | LARIN, KIRILL V | reporter.nih.gov |
| Organization and Function of Visual Cortical Feedback Systems | NIH | National Eye Institute | 2021 to 2025 | $2,315,061 | May 1, 2012 | April 30, 2028 | CALLAWAY, EDWARD M | reporter.nih.gov |
| Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision loss | NIH | National Eye Institute | 2021 to 2024 | $2,314,921 | May 1, 2020 | April 30, 2026 | GRUMBACH, ISABELLA MARIA | reporter.nih.gov |
| Harvard-Vision Clinical Scientist Development Program | NIH | National Eye Institute | 2021 to 2025 | $2,309,471 | September 30, 2004 | March 31, 2026 | DANA, REZA | reporter.nih.gov |
| Synaptic and circuit mechanisms of compensation following loss of cone inputs in the mature retina | NIH | National Eye Institute | 2021 to 2025 | $2,308,324 | February 1, 2019 | June 30, 2028 | DUNN, FELICE A | reporter.nih.gov |
| Quantitative assessment of glaucomatous conventional outflow dynamics | NIH | National Eye Institute | 2021 to 2025 | $2,300,011 | May 1, 2019 | August 31, 2029 | FARSIU, SINA | reporter.nih.gov |
| Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling. | NIH | National Eye Institute | 2021 to 2024 | $2,298,831 | June 1, 2020 | May 31, 2026 | DI POLO, ADRIANA | reporter.nih.gov |
| How retinal silencing restores synaptic strength in visual cortex of adult amblyopia | NIH | National Eye Institute | 2025 | $2,294,505 | September 1, 2025 | June 30, 2029 | BEAR, MARK F | reporter.nih.gov |
| Targeting Tissue Biomechanics for Treatment of Glaucoma | NIH | National Eye Institute | 2021 to 2025 | $2,286,871 | September 1, 2010 | August 31, 2026 | KUCHTEY, RACHEL W | reporter.nih.gov |
| Characterizing Human RPE Cell Proliferation to Advance Endogenous Regeneration | NIH | National Eye Institute | 2021 to 2024 | $2,286,488 | February 1, 2021 | November 30, 2025 | TEMPLE, SALLY | reporter.nih.gov |
| Neuroprotective Role of Sirt6 in Glaucoma | NIH | National Eye Institute | 2021 to 2024 | $2,284,362 | June 1, 2020 | May 31, 2026 | LIU, HUA | reporter.nih.gov |
| Prevalence effects in visual search: Theoretical and practical implications | NIH | National Eye Institute | 2021 to 2025 | $2,283,459 | April 1, 2007 | June 30, 2029 | WOLFE, JEREMY M | reporter.nih.gov |
| Notch in Angiogenesis and Vascular Biology | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,281,892 | July 17, 2012 | December 31, 2026 | KITAJEWSKI, JAN K. | reporter.nih.gov |
| Spatiotemporal representation in ventral visual pathway | NIH | National Eye Institute | 2021 to 2025 | $2,275,018 | February 1, 2021 | November 30, 2026 | PASUPATHY, ANITHA | reporter.nih.gov |
| Metabolic dysfunction from ECM remodeling in diseases of human RPE | NIH | National Eye Institute | 2022 to 2025 | $2,274,411 | September 1, 2022 | June 30, 2027 | CHAO, JENNIFER RAYMING | reporter.nih.gov |
| Binocular Vision, Amblyopia, and Refractive Development | NIH | National Eye Institute | 2021 to 2025 | $2,272,941 | May 1, 2012 | January 31, 2028 | BIRCH, EILEEN ELIZABETH | reporter.nih.gov |
| Elucidation of novel anti-angiogenic therapies for the prevention and treatment of neovascular glaucoma | NIH | National Eye Institute | 2021 to 2024 | $2,271,712 | September 30, 2021 | August 31, 2025 | MONTANER, SILVIA V | reporter.nih.gov |
| Neural algorithms underlying diversity in visual feature integration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,268,726 | September 15, 2020 | June 30, 2026 | VON REYN, CATHERINE R | reporter.nih.gov |
| Delineating the role of TIMP3 in macular degeneration | NIH | National Eye Institute | 2021 to 2025 | $2,268,028 | September 30, 2017 | May 31, 2027 | SINGH, RUCHIRA | reporter.nih.gov |
| Visual perception as a window onto prediction anomalies in schizophrenia | NIH | National Institute of Mental Health | 2021 to 2025 | $2,266,778 | April 1, 2021 | January 31, 2027 | THAKKAR, KATHARINE NATASHA | reporter.nih.gov |
| Complement factor H modulates lipoprotein clearance in AMD | NIH | National Eye Institute | 2021 to 2024 | $2,266,452 | August 1, 2020 | July 31, 2025 | BOWES RICKMAN, CATHERINE | reporter.nih.gov |
| Training Program in Vision Science | NIH | National Eye Institute | 2021 to 2025 | $2,265,806 | July 1, 1982 | July 31, 2029 | FLEISZIG, SUZANNE MJ | reporter.nih.gov |
| The production, learning, and behavioral significance of outcome prediction signaling in the corticostriatal circuit | NIH | National Institute of Mental Health | 2021 to 2024 | $2,263,280 | August 1, 2020 | May 31, 2026 | SHULER, MARSHALL GILMER | reporter.nih.gov |
| Mechanisms of neural patterning and the generation of neural diversity in the brain | NIH | National Eye Institute | 2021 to 2025 | $2,259,527 | February 1, 2007 | May 31, 2029 | DESPLAN, CLAUDE | reporter.nih.gov |
| Structure-Function Studies of Aquaporin 0 in Lens Development and Physiology | NIH | National Eye Institute | 2021 to 2025 | $2,258,153 | February 1, 2021 | January 31, 2027 | TOBIAS, DOUGLAS J | reporter.nih.gov |
| Neurophysiological circuits underlying visual attention | NIH | National Eye Institute | 2021 to 2025 | $2,257,492 | September 1, 1986 | December 31, 2026 | MAUNSELL, JOHN H.R. | reporter.nih.gov |
| Molecular Mechanisms of Emmetropization and Experimental Myopia at Single Cell Resolution | NIH | National Eye Institute | 2022 to 2025 | $2,255,215 | September 30, 2022 | August 31, 2027 | BENAVENTE-PEREZ, ALEXANDRA | reporter.nih.gov |
| Paradigms of maintaining anterior segment homeostasis | NIH | National Eye Institute | 2021 to 2025 | $2,254,974 | September 30, 2011 | March 31, 2028 | MENKO, A. SUE | reporter.nih.gov |
| Interrogating the intersection between diet and ocular autoimmunity | NIH | National Eye Institute | 2022 to 2025 | $2,251,397 | April 1, 2022 | March 31, 2027 | PLAFKER, SCOTT M | reporter.nih.gov |
| Connectome of circuits within and between thalamus and cortex | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,245,388 | August 1, 2020 | May 31, 2025 | SHERMAN, S. MURRAY | reporter.nih.gov |
| Imaging Structure and Function of Photoreceptors | NIH | National Eye Institute | 2022 to 2025 | $2,243,735 | September 1, 2007 | April 30, 2027 | MILLER, DONALD T | reporter.nih.gov |
| Elucidating the role of the oculomotor circuit in free viewing visual search | NIH | National Eye Institute | 2022 to 2025 | $2,242,874 | September 30, 2022 | June 30, 2027 | BISLEY, JAMES | reporter.nih.gov |
| Genetic Basis of Dorso-Ventral Patterning in the Drosophila Eye | NIH | National Eye Institute | 2021 to 2025 | $2,241,926 | August 1, 2021 | June 30, 2027 | SINGH, AMIT | reporter.nih.gov |
| Targeting Gq pathway in uveal melanoma | NIH | National Cancer Institute | 2022 to 2025 | $2,239,582 | September 7, 2022 | August 31, 2027 | CHEN, XU | reporter.nih.gov |
| Mitochondrial Protection in Glaucomatous Optic Neuropathy | NIH | National Eye Institute | 2021 to 2023 | $2,238,814 | September 1, 2020 | June 30, 2024 | JU, WONKYU | reporter.nih.gov |
| Determinants of the periocular microbiome | NIH | National Eye Institute | 2023 to 2025 | $2,236,328 | July 1, 2023 | June 30, 2026 | VAN GELDER, RUSSELL N. | reporter.nih.gov |
| Long-term Follow-up of the Systemic Immunosuppressive Therapy for Eye Diseases Cohort | NIH | National Eye Institute | 2025 | $2,236,075 | May 1, 2004 | August 31, 2029 | KEMPEN, JOHN H | reporter.nih.gov |
| Village-Integrated Eye Worker Trial II (VIEW II) Extension | NIH | National Eye Institute | 2024 to 2025 | $2,234,860 | September 1, 2024 | August 31, 2029 | KEENAN, JEREMY DAVID | reporter.nih.gov |
| Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye | NIH | National Eye Institute | 2021 to 2025 | $2,231,877 | August 1, 2020 | March 31, 2030 | HUANG, ALEX | reporter.nih.gov |
| Novel Biomarkers of Small Vessel Contributions to Vascular Cognitive Impairment and Dementia (VCID) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,230,406 | August 15, 2019 | June 30, 2025 | DETRE, JOHN A | reporter.nih.gov |
| Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,229,327 | December 1, 2015 | July 31, 2026 | CARRUTHERS, VERNON BRUCE | reporter.nih.gov |
| GIPC3, multifunctional myosin adaptor in mammalian auditory hair cells | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,228,730 | June 10, 2020 | May 31, 2026 | FROLENKOV, GREGORY I | reporter.nih.gov |
| Calcium channels in retinal photoreceptors | NIH | National Eye Institute | 2021 to 2025 | $2,226,486 | March 1, 2017 | April 30, 2026 | LEE, AMY | reporter.nih.gov |
| Retinal Contributions to Vision Loss in Albinism | NIH | National Eye Institute | 2022 to 2025 | $2,224,859 | July 1, 2022 | June 30, 2027 | CARROLL, JOSEPH | reporter.nih.gov |
| Cornea biomechanical analysis with Brillouin microscopy | NIH | National Eye Institute | 2021 to 2025 | $2,214,967 | February 1, 2018 | June 30, 2028 | SCARCELLI, GIULIANO | reporter.nih.gov |
| Cortical circuit mechanisms of visual shape processing | NIH | National Eye Institute | 2021 to 2025 | $2,214,656 | January 1, 2021 | November 30, 2026 | EL-SHAMAYLEH, YASMINE | reporter.nih.gov |
| Understanding the neurocognitive mechanisms of alpha-band brain oscillations using concurrent EEG-fMRI recordings | NIH | National Institute of Mental Health | 2022 to 2025 | $2,214,107 | September 19, 2022 | July 31, 2027 | LENARTOWICZ, AGATHA | reporter.nih.gov |
| Exploring Mechanisms in Retinal Development/Homeostasis, Retinal Immune Surveillance and Diabetic Retinopathy Using Forward Genetics | NIH | National Eye Institute | 2021 to 2025 | $2,207,571 | September 30, 2021 | July 31, 2027 | UFRET-VINCENTY, RAFAEL | reporter.nih.gov |
| Viral and Host Factors in Herpetic Diseases | NIH | National Eye Institute | 2021 to 2025 | $2,206,794 | January 9, 1992 | June 30, 2027 | LEIB, DAVID A | reporter.nih.gov |
| Stimulus competition and visuospatial selection: Neural circuit and computational mechanisms | NIH | National Eye Institute | 2021 to 2025 | $2,205,331 | March 1, 2017 | May 31, 2026 | MYSORE, SHREESH P | reporter.nih.gov |
| Deciphering the molecular mechanisms in photoreceptor wiring | NIH | National Eye Institute | 2021 to 2025 | $2,204,600 | September 30, 2021 | June 30, 2026 | ZUNIGA-SANCHEZ, ELIZABETH | reporter.nih.gov |
| Advancing novel therapies for optic neuropathy with a nonhuman primate model | NIH | National Eye Institute | 2023 to 2025 | $2,203,297 | March 1, 2023 | February 29, 2028 | THOMASY, SARA MICHELLE | reporter.nih.gov |
| Decoding the Mechanisms for Selective Retinotectal Circuit Wiring | NIH | National Eye Institute | 2021 to 2025 | $2,200,264 | January 1, 2020 | July 31, 2029 | DUAN, XIN | reporter.nih.gov |
| Adaptive visual representation in human posterior parietal cortex | NIH | National Eye Institute | 2021 to 2025 | $2,200,207 | May 1, 2020 | August 31, 2028 | XU, YAODA | reporter.nih.gov |
| Serine control of retinal neovascularization in retinopathy | NIH | National Eye Institute | 2021 to 2025 | $2,199,225 | May 1, 2021 | March 31, 2027 | FU, ZHONGJIE | reporter.nih.gov |
| Contribution of sensorimotor function to risk and pathogenic mechanisms of Alzheimer's disease and related dementias | NIH | National Institute on Aging | 2021 to 2023 | $2,196,155 | February 1, 2019 | November 30, 2025 | SCHRACK, JENNIFER ANN | reporter.nih.gov |
| Flexible normalization in ferret V1: computational modeling and 2-photon imaging | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,195,234 | August 1, 2021 | June 30, 2027 | SMITH, GORDON BRAWN | reporter.nih.gov |
| Glucocorticoids, ocular hypertension and glaucoma | NIH | National Eye Institute | 2021 to 2024 | $2,194,891 | September 30, 2020 | August 31, 2025 | CLARK, ABBOT FREDERICK | reporter.nih.gov |
| Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based Metrics | NIH | National Eye Institute | 2022 to 2024 | $2,194,309 | September 1, 2019 | August 31, 2025 | KASHANI, AMIR H | reporter.nih.gov |
| eNOS-Dependent Mechanoregulation of Intraocular Pressure | NIH | National Eye Institute | 2021 to 2025 | $2,192,072 | April 1, 2012 | July 31, 2027 | STAMER, W DANIEL | reporter.nih.gov |
| Sustained release of fenofibrate for the treatment of diabetic retinopathy | NIH | National Eye Institute | 2022 to 2025 | $2,189,213 | September 1, 2022 | April 30, 2025 | XU, QINGGUO | reporter.nih.gov |
| Mechanisms controlling stochastic gene expression during eye development | NIH | National Eye Institute | 2021 to 2025 | $2,184,314 | August 1, 2015 | June 30, 2029 | JOHNSTON, ROBERT JOHN | reporter.nih.gov |
| How Do Synaptic Connections Change in Demyelinating Disease? | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,182,790 | February 1, 2021 | January 31, 2026 | SCHAFER, DOROTHY PATRICIA | reporter.nih.gov |
| Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanism | NIH | National Eye Institute | 2022 to 2025 | $2,182,784 | February 1, 2022 | November 30, 2026 | HU, YANG | reporter.nih.gov |
| NeuroEbola | NIH | National Eye Institute | 2021 to 2024 | $2,178,941 | September 30, 2021 | July 31, 2026 | TSHALA-KATUMBAY, DANIEL DESIRE | reporter.nih.gov |
| Function, diversity, and circuitry of parallel retinal ganglion cell pathways | NIH | National Eye Institute | 2021 to 2025 | $2,177,975 | March 1, 2018 | May 31, 2028 | MANOOKIN, MICHAEL B | reporter.nih.gov |
| Pathogenesis of Bacterial Keratitis | NIH | National Eye Institute | 2021 to 2025 | $2,177,731 | April 1, 2003 | May 31, 2028 | PEARLMAN, ERIC | reporter.nih.gov |
| The Natural History of LCHAD Retinopathy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,176,733 | September 13, 2019 | November 30, 2025 | GILLINGHAM, MELANIE B | reporter.nih.gov |
| GENETICS OF ENDOCYTIC TRAFFICKING IN THE DROSOPHILA EYE | NIH | National Eye Institute | 2021 to 2025 | $2,176,054 | September 30, 2023 | August 31, 2027 | KRAMER, HELMUT J | reporter.nih.gov |
| Molecular Mechanisms of Severe Diabetic Retinopathy | NIH | National Eye Institute | 2021 to 2025 | $2,169,448 | February 1, 2020 | April 30, 2029 | ZHANG, SARAH X | reporter.nih.gov |
| Chemigenetic voltage indicators for far-red and two-photon imaging in vivo | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,164,867 | September 1, 2023 | August 31, 2026 | ABDELFATTAH, AHMED | reporter.nih.gov |
| Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid | NIH | National Eye Institute | 2021 to 2024 | $2,163,658 | September 1, 2020 | June 30, 2024 | STAMBOLIAN, DWIGHT EDWARD | reporter.nih.gov |
| Function and Structure Adaptations in Forebrain Development | NIH | National Institute of Mental Health | 2021 to 2023 | $2,160,588 | July 1, 2002 | March 31, 2025 | LEVITT, PAT | reporter.nih.gov |
| Vulnerable and Resilient Cells in Retinal Degeneration | NIH | National Eye Institute | 2021 to 2025 | $2,157,192 | March 1, 2000 | June 30, 2028 | CHEN, SHIMING | reporter.nih.gov |
| Horton_Admin_Supplement_EY029703 | NIH | National Eye Institute | 2021 to 2024 | $2,157,165 | February 1, 2019 | January 31, 2025 | HORTON, JONATHAN C | reporter.nih.gov |
| Gene Expression Regulatory Pathways and Retinal Ganglion Cell Neuroprotection | NIH | National Eye Institute | 2021 to 2024 | $2,156,051 | February 1, 2021 | November 30, 2024 | KAPILOFF, MICHAEL SETH | reporter.nih.gov |
| Hair Bundle Proteins | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,155,174 | July 1, 1994 | June 30, 2029 | BARR-GILLESPIE, PETER GORDON | reporter.nih.gov |
| TRPM8 in eye health and disease | NIH | National Eye Institute | 2021 to 2025 | $2,153,921 | September 30, 2020 | April 30, 2029 | LEE, SEOK-YONG | reporter.nih.gov |
| UIC K12 independent Clinical Vision Scientist Development Program | NIH | National Eye Institute | 2021 to 2025 | $2,152,132 | September 1, 2011 | March 31, 2029 | DJALILIAN, ALI R | reporter.nih.gov |
| Melanopsin Photoreception and Signaling | NIH | National Eye Institute | 2021 to 2025 | $2,151,342 | June 1, 2022 | May 31, 2027 | YAU, KING-WAI | reporter.nih.gov |
| Retinal eye-tracking as a prognostic tool for traumatic brain injury and concussion | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $2,150,115 | July 16, 2016 | August 31, 2025 | SHEEHY, CHRISTY KATHLEEN | reporter.nih.gov |
| Training Program in Neuroscience | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,144,288 | July 1, 1999 | June 30, 2026 | KNIERIM, JAMES J | reporter.nih.gov |
| Dexamethasone as an Effective Therapy for Ocular Injuries by Vesicating Agents. | NIH | National Eye Institute | 2021 to 2023 | $2,143,923 | August 1, 2020 | July 31, 2025 | AGARWAL, RAJESH | reporter.nih.gov |
| Defining mechanisms driving dry eye disease progression | NIH | National Eye Institute | 2021 to 2025 | $2,142,678 | August 1, 2021 | July 31, 2026 | KNOX, SARAH MONICA | reporter.nih.gov |
| Protein tyrosine phosphatase non-receptor 14 in vascular stability and remodeling | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,141,603 | March 15, 2023 | February 28, 2027 | AKHURST, ROSEMARY J | reporter.nih.gov |
| Vision, Attention and Eye Movements at the Scale of the Foveola | NIH | National Eye Institute | 2021 to 2025 | $2,139,353 | February 1, 2019 | January 31, 2028 | POLETTI, MARTINA | reporter.nih.gov |
| Visual Remediation in Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2023 | $2,138,056 | February 8, 2018 | July 31, 2025 | SILVERSTEIN, STEVEN M | reporter.nih.gov |
| Non-canonical GABAergic Pathways in the Visual System | NIH | National Eye Institute | 2021 to 2024 | $2,137,907 | July 1, 2020 | May 31, 2025 | SCHMIDT, TIFFANY M. | reporter.nih.gov |
| State-dependent modulation of retinothalamic axonal boutons | NIH | National Eye Institute | 2021 to 2025 | $2,137,140 | June 1, 2021 | May 31, 2027 | ANDERMANN, MARK L | reporter.nih.gov |
| Neurovascular Consequences of Non-Pulsatile Flow from Left Ventricular Assist Devices | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,135,855 | January 1, 2022 | December 31, 2026 | WILLEY, JOSHUA ZEBADIAH | reporter.nih.gov |
| Fluorometholone as Adjunctive Therapy for Trachomatous Trichiasis Surgery | NIH | National Eye Institute | 2021 to 2023 | $2,135,562 | September 30, 2019 | June 30, 2025 | KEMPEN, JOHN H | reporter.nih.gov |
| Characterizing Vision Impairment and Its Impact on Independence in Older Adults | NIH | National Eye Institute | 2023 to 2025 | $2,135,423 | February 1, 2023 | January 31, 2028 | GOWER, EMILY W | reporter.nih.gov |
| Physiological and perceptual examination of vision restoration | NIH | National Eye Institute | 2021 to 2023 | $2,134,803 | February 1, 2011 | January 31, 2025 | MERIGAN, WILLIAM H | reporter.nih.gov |
| Peptides and small-molecules targeting signaling proteins and protein-protein interfaces | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,134,024 | September 15, 2020 | June 30, 2030 | VASHISTH, HARISH | reporter.nih.gov |
| Transcriptional control of retinal neuron specification and maturation. | NIH | National Eye Institute | 2021 to 2025 | $2,133,062 | January 1, 2021 | December 31, 2026 | WRIGHT, KEVIN | reporter.nih.gov |
| Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss | NIH | National Eye Institute | 2022 to 2025 | $2,132,927 | September 30, 2022 | May 31, 2027 | MOSS, HEATHER ELSPETH | reporter.nih.gov |
| Theranostics of Photoreceptor-RPE-Choroid Neurovascular Unit in Eye Diseases: | NIH | National Eye Institute | 2021 to 2025 | $2,128,279 | February 1, 2017 | February 28, 2027 | ZAWADZKI, ROBERT J | reporter.nih.gov |
| Human Retinal Imaging Biomarkers for FTLD-Tau in Relation to FTLD-TDP and Nonamnestic AD | NIH | National Institute on Aging | 2023 | $2,126,420 | September 1, 2023 | August 31, 2026 | KIM, BENJAMIN J. | reporter.nih.gov |
| Targeting the retinoic acid signaling pathway for mitigating visual impairmen in retinal degenerative disorders | NIH | National Eye Institute | 2021 to 2024 | $2,123,221 | September 1, 2015 | July 31, 2025 | KRAMER, RICHARD H | reporter.nih.gov |
| A Holistic Approach to Understanding Small Heat Shock Protein Mechanism | NIH | National Eye Institute | 2021 to 2024 | $2,121,071 | May 1, 2007 | April 30, 2026 | KLEVIT, RACHEL E | reporter.nih.gov |
| Determinants of Rod and Cone Response Characteristics | NIH | National Eye Institute | 2021 to 2025 | $2,119,945 | July 1, 1986 | August 31, 2029 | HURLEY, JAMES BRYANT | reporter.nih.gov |
| Retinal Disease: Molecular Basis and Pathophysiology | NIH | National Eye Institute | 2023 to 2025 | $2,119,415 | February 1, 1998 | April 30, 2027 | NISHINA, PATSY M | reporter.nih.gov |
| Quantitative MRI for Pediatric Optic Pathway Glioma Treatment Response | NIH | National Cancer Institute | 2022 to 2024 | $2,119,273 | June 17, 2020 | July 31, 2025 | AVERY, ROBERT ANDREW | reporter.nih.gov |
| Microtubule-based Transport in Lacrimal Gland Function | NIH | National Eye Institute | 2021 to 2025 | $2,118,262 | July 1, 1996 | June 30, 2027 | HAMM-ALVAREZ, SARAH F | reporter.nih.gov |
| Cross-modal enhancement of auditory plasticity and performance in adults | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,117,210 | July 1, 2020 | June 30, 2025 | LEE, HEY-KYOUNG | reporter.nih.gov |
| Extracellular Matrix and Outflow Resistance | NIH | National Eye Institute | 2021 to 2025 | $2,116,406 | August 1, 2010 | May 31, 2026 | KELLER, KATE E | reporter.nih.gov |
| Cell Biology of Astrocyte-Ganglion Cell Interactions in the Retina and Optic Nerve | NIH | National Eye Institute | 2021 to 2025 | $2,116,151 | September 30, 2009 | April 30, 2029 | JAKOBS, TATJANA CLAUDIA | reporter.nih.gov |
| PHOTOTRANSDUCTION IN HEALTH AND DISEASE - Administrative Supplement | NIH | National Eye Institute | 2021 to 2025 | $2,114,088 | September 30, 2011 | February 28, 2026 | PARK, PAUL S | reporter.nih.gov |
| Validation of Retinal Abeta as a Potential Biomarker of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $2,113,690 | September 1, 2019 | November 30, 2025 | PHAM, WELLINGTON | reporter.nih.gov |
| Development of CRISPR/Cas9-based exon-skipping strategies for the treatment of USH-associated deafness | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2024 | $2,113,099 | August 22, 2022 | June 30, 2027 | LIU, XUE Z | reporter.nih.gov |
| Olfactory neuromodulation of visual circuits and behavior | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,108,768 | April 1, 2021 | March 31, 2027 | FRYE, MARK ARTHUR | reporter.nih.gov |
| iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,107,250 | January 15, 2021 | December 31, 2025 | WEINREB, ROBERT N | reporter.nih.gov |
| Visual mechanisms of intermediate distance space perception during self-motion | NIH | National Eye Institute | 2021 to 2024 | $2,104,562 | September 30, 2021 | June 30, 2026 | HE, ZIJIANG | reporter.nih.gov |
| A multi-modal wireless oscillator array for high-resolution mapping of neurovascular coupling | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,102,537 | August 18, 2022 | July 31, 2025 | QIAN, CHUNQI | reporter.nih.gov |
| DICER1 deficiency in aberrant chorioretinal neovascularization | NIH | National Eye Institute | 2021 to 2024 | $2,101,749 | June 1, 2021 | May 31, 2025 | GELFAND, BRADLEY DAVID | reporter.nih.gov |
| Active Social Vision: How the Brain Processes Visual Information During Natural Social Perception | NIH | National Institute of Mental Health | 2023 to 2025 | $2,098,897 | February 17, 2023 | December 31, 2027 | GHUMAN, AVNIEL S | reporter.nih.gov |
| Role of fixational eye movements and saccades in processing spatial information in V1-V2-V4 networks | NIH | National Eye Institute | 2022 to 2025 | $2,094,934 | September 1, 2022 | May 31, 2027 | PURPURA, KEITH P. | reporter.nih.gov |
| Production and progression of premalignant retinoblastoma lesions. | NIH | National Cancer Institute | 2021 to 2025 | $2,094,221 | March 1, 2011 | July 31, 2029 | COBRINIK, DAVID | reporter.nih.gov |
| Cell Based Immunomodulation to Promote Post-Infarct Myocardial Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,094,218 | December 10, 2022 | November 30, 2027 | GHANTA, RAVI K | reporter.nih.gov |
| Unfolded Protein Response in Drosophila models of Retinitis Pigmentosa | NIH | National Eye Institute | 2021 to 2025 | $2,093,248 | August 1, 2010 | June 30, 2027 | RYOO, HYUNG D | reporter.nih.gov |
| Signal Processing in the Inner Retina | NIH | National Eye Institute | 2021 to 2024 | $2,091,956 | May 7, 2007 | June 30, 2025 | DEVRIES, STEVEN H | reporter.nih.gov |
| OCTA and Glaucoma Progression in the Non-Human Primate | NIH | National Eye Institute | 2022 to 2025 | $2,090,272 | August 1, 2022 | May 31, 2027 | PATEL, NIMESH BHIKHU | reporter.nih.gov |
| BP-ENDURE at the University of Nevada | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,088,568 | January 15, 2021 | May 31, 2026 | WEIERICH, MARIANN R | reporter.nih.gov |
| CLARIN 1 RETINAL FUNCTION AND THERAPEUTIC IMPLICATIONS FOR USH3 | NIH | National Eye Institute | 2023 to 2025 | $2,087,697 | September 1, 2016 | June 30, 2027 | DINCULESCU, ASTRA | reporter.nih.gov |
| Neuronal responses to chronic demyelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,087,270 | April 1, 2021 | January 31, 2026 | EMERY, BEN | reporter.nih.gov |
| Development of direction selectivity in retina | NIH | National Eye Institute | 2021 to 2025 | $2,085,963 | July 1, 2009 | November 30, 2026 | FELLER, MARLA | reporter.nih.gov |
| Structural basis of BBSome-mediated ciliary exit | NIH | National Eye Institute | 2021 to 2023 | $2,085,339 | June 1, 2020 | May 31, 2024 | NACHURY, MAXENCE V | reporter.nih.gov |
| Parameterizing the relationship between motor cortical reactivation during sleep and motor skill acquisition in the freely behaving marmoset | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,085,071 | September 1, 2023 | August 31, 2026 | HATSOPOULOS, NICHOLAS G | reporter.nih.gov |
| Developing a Translation Pipeline for VHL Mutant Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $2,084,051 | April 1, 2019 | March 31, 2028 | MCDERMOTT, DAVID | reporter.nih.gov |
| Late-stage Pre-clinical Development and GMP Production of a First-in-Class Extended Release IOP-lowering Formulation | NIH | National Eye Institute | 2024 to 2025 | $2,081,932 | September 1, 2024 | August 31, 2026 | JOHNSON, DIANNA AMMONS | reporter.nih.gov |
| Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy | NIH | National Eye Institute | 2021 to 2025 | $2,081,188 | June 1, 2021 | May 31, 2027 | PUNZO, CLAUDIO | reporter.nih.gov |
| Circuit specializations of developing visual networks | NIH | National Eye Institute | 2021 to 2025 | $2,080,505 | September 1, 2013 | August 31, 2028 | COLONNESE, MATTHEW TODD | reporter.nih.gov |
| Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection | NIH | National Eye Institute | 2021 to 2024 | $2,079,783 | January 1, 2021 | December 31, 2025 | ARUMUGASWAMI, VAITHILINGARAJA | reporter.nih.gov |
| Mechanisms governing development of large-scale networks in visual cortex | NIH | National Eye Institute | 2021 to 2025 | $2,078,940 | February 1, 2020 | April 30, 2029 | SMITH, GORDON BRAWN | reporter.nih.gov |
| Lacrimal Gland Repair Using Progenitor Cells | NIH | National Eye Institute | 2021 to 2025 | $2,077,504 | January 1, 2016 | June 30, 2027 | MAKARENKOVA, HELEN P. | reporter.nih.gov |
| Impact of local network dynamics on visual cortex function | NIH | National Eye Institute | 2021 to 2025 | $2,077,159 | April 1, 2013 | November 30, 2025 | CARDIN, JESSICA A | reporter.nih.gov |
| Therapeutic control of HSK by CD80 | NIH | National Eye Institute | 2021 to 2025 | $2,074,975 | September 1, 2016 | November 30, 2026 | GHIASI, HOMAYON | reporter.nih.gov |
| Origins of plasticity in the establishment of binocular vision | NIH | National Eye Institute | 2021 to 2025 | $2,074,108 | September 1, 2013 | July 31, 2029 | TRACHTENBERG, JOSHUA | reporter.nih.gov |
| Epac1 as a novel therapeutic target for diabetic retinopathy | NIH | National Eye Institute | 2022 to 2025 | $2,073,919 | July 1, 2025 | June 30, 2026 | CHENG, XIAODONG | reporter.nih.gov |
| A hyperspectral approach to RPE fluorophores in AMD | NIH | National Eye Institute | 2022 to 2025 | $2,071,603 | July 1, 2017 | April 30, 2027 | CURCIO, CHRISTINE A | reporter.nih.gov |
| Eye as a Window into Brain Health in Pediatric Hydrocephalus | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,071,204 | April 1, 2023 | March 31, 2028 | HWANG, MISUN | reporter.nih.gov |
| Mechanisms of Synaptic Specificity in Visual Circuits | NIH | National Eye Institute | 2022 to 2025 | $2,070,586 | September 30, 2015 | April 30, 2027 | TRIPLETT, JASON | reporter.nih.gov |
| Adaptive population codes for flexible visually-guided behaviors | NIH | National Eye Institute | 2021 to 2025 | $2,069,483 | June 1, 2025 | May 31, 2029 | SERENCES, JOHN T | reporter.nih.gov |
| Assessment of the Complement Pathway in a RPE/choroid Tissue Chip | NIH | National Eye Institute | 2024 to 2025 | $2,066,956 | September 1, 2024 | April 30, 2028 | ROHRER, BAERBEL | reporter.nih.gov |
| Phosphosulindac for dry eye | NIH | National Eye Institute | 2022 to 2023 | $2,065,744 | August 1, 2020 | January 31, 2025 | KOMNINOU, DESPINA | reporter.nih.gov |
| Glycosylation in ocular surface health and disease | NIH | National Eye Institute | 2021 to 2025 | $2,064,667 | August 1, 2016 | July 31, 2028 | ARGUESO, PABLO | reporter.nih.gov |
| Characterization of the role of MIF on retinal health and disease | NIH | National Eye Institute | 2021 to 2025 | $2,063,176 | September 1, 2021 | July 31, 2027 | CEBULLA, COLLEEN MARIE | reporter.nih.gov |
| Evaluating the rehabilitative potential of tactile number expressions for multisensory vision and hearing loss using wearable haptics | NIH | National Eye Institute | 2022 to 2025 | $2,061,545 | August 1, 2022 | July 31, 2027 | GAGNE, DEANNA | reporter.nih.gov |
| In Vivo Function and Metabolism Evaluation of Glaucomatous RGCs by Two-Photon Scanning Laser Ophthalmology | NIH | National Eye Institute | 2023 to 2025 | $2,059,317 | July 1, 2023 | March 31, 2028 | HU, YANG | reporter.nih.gov |
| Enhancing cone survival in retinitis pigmentosa through cell-specific therapeutic CRISPR editing of a roxadustat target | NIH | National Eye Institute | 2022 to 2025 | $2,055,441 | June 1, 2022 | May 31, 2027 | TSANG, STEPHEN H | reporter.nih.gov |
| Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma | NIH | National Eye Institute | 2022 to 2025 | $2,054,009 | September 1, 2011 | June 30, 2027 | WIGGS, JANEY L | reporter.nih.gov |
| Representation of navigational and driving-related information across human brain | NIH | National Eye Institute | 2021 to 2025 | $2,051,873 | May 1, 2021 | March 31, 2026 | GALLANT, JACK L | reporter.nih.gov |
| Stanford K12 Clinician-Scientist Career Development Program | NIH | National Eye Institute | 2022 to 2025 | $2,050,880 | July 1, 2022 | March 31, 2027 | GOLDBERG, JEFFREY L | reporter.nih.gov |
| Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma | NIH | National Cancer Institute | 2023 to 2024 | $2,050,000 | September 17, 2020 | March 31, 2026 | OFFERMANN, MARGARET KENNY | reporter.nih.gov |
| Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration | NIH | National Eye Institute | 2021 to 2025 | $2,047,171 | September 1, 2015 | March 31, 2030 | HU, YANG | reporter.nih.gov |
| Bioengineering Cornea with Autologous Stem Cells | NIH | National Eye Institute | 2022 to 2025 | $2,045,272 | May 1, 2016 | March 31, 2027 | FEINBERG, ADAM WALTER | reporter.nih.gov |
| Investigation of endomucin as a novel regulator of angiogenesis | NIH | National Eye Institute | 2021 to 2024 | $2,044,289 | February 1, 2017 | July 31, 2025 | D'AMORE, PATRICIA ANN | reporter.nih.gov |
| High-Resolution Flow Imaging of Optic Nerve Head and Retrolaminar Microvascular Circulation | NIH | National Eye Institute | 2023 to 2025 | $2,044,254 | September 30, 2023 | June 30, 2027 | ZHOU, QIFA | reporter.nih.gov |
| HPSE in Ocular Herpes Infection | NIH | National Eye Institute | 2021 to 2025 | $2,043,774 | September 1, 2018 | August 31, 2027 | SHUKLA, DEEPAK | reporter.nih.gov |
| Neural Circuits that Process Visual Information | NIH | National Eye Institute | 2021 to 2025 | $2,042,750 | July 1, 1993 | July 31, 2028 | HIRSCH, JUDITH A | reporter.nih.gov |
| Establishing a Unified Framework of Spontaneous Brain Activity in Perception | NIH | National Eye Institute | 2021 to 2025 | $2,042,477 | September 1, 2021 | June 30, 2027 | HE, BIYU JADE | reporter.nih.gov |
| Interdisciplinary Predoctoral Neuroscience Training Program in the Neuroscience Graduate Program. | NIH | National Institute of Mental Health | 2021 to 2025 | $2,040,438 | July 1, 1999 | August 31, 2026 | SHEINBERG, DAVID L | reporter.nih.gov |
| BRAIN CONNECTS: Light microscopy for cell-type specific mesoscale to nanoscale dense connectomics | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $2,039,359 | August 11, 2025 | May 31, 2028 | REID, R CLAY | reporter.nih.gov |
| A Widefield, Handheld OCT system for Patients who are Unable to Cooperate | NIH | National Eye Institute | 2024 to 2025 | $2,037,009 | May 1, 2022 | August 31, 2026 | VIEHLAND, CHRISTIAN | reporter.nih.gov |
| Muller cell activation and remodeling in AMD. | NIH | National Eye Institute | 2021 to 2025 | $2,034,594 | February 1, 2021 | December 31, 2025 | EDWARDS, MALIA MICHELLE | reporter.nih.gov |
| New models, new approaches, new horizons in corneal nerve regeneration | NIH | National Eye Institute | 2022 to 2025 | $2,033,936 | March 1, 2022 | February 28, 2027 | LEE, VIVIAN | reporter.nih.gov |
| Embryonic vascular stem-progenitors for treatment of ischemic retinopathies | NIH | National Eye Institute | 2021 to 2024 | $2,033,849 | February 1, 2021 | January 31, 2026 | ZAMBIDIS, ELIAS T. | reporter.nih.gov |
| Learning to see again: biological constraints on cortical plasticity and the implications for sight restoration technologies | NIH | National Eye Institute | 2021 to 2025 | $2,032,811 | May 1, 2021 | April 30, 2027 | FINE, IONE | reporter.nih.gov |
| RORalpha mediates chronic subretinal inflammation associated with AMD | NIH | National Eye Institute | 2022 to 2025 | $2,030,820 | December 2, 2014 | May 31, 2027 | CHEN, JING | reporter.nih.gov |
| Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO) | NIH | National Eye Institute | 2021 to 2025 | $2,027,481 | March 1, 2021 | February 28, 2027 | DOAN, THUY A | reporter.nih.gov |
| International Advancing genomics through the AMD Genomics Consortium (IAMDGC) | NIH | National Eye Institute | 2021 to 2024 | $2,023,778 | April 1, 2012 | June 30, 2026 | HAINES, JONATHAN L | reporter.nih.gov |
| Neural mechanisms of perceptual abnormalities and their malleability in body dysmorphic disorder | NIH | National Institute of Mental Health | 2021 to 2025 | $2,023,425 | July 23, 2020 | May 31, 2027 | FEUSNER, JAMIE | reporter.nih.gov |
| Neurotoxicity of Reactive Astrocyte-secreted Lipids in Neurodegenerative Disease | NIH | National Eye Institute | 2022 to 2025 | $2,023,416 | March 1, 2022 | December 31, 2026 | LIDDELOW, SHANE | reporter.nih.gov |
| Universal optical coherence polarimetry | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,020,013 | July 15, 2022 | April 30, 2026 | VILLIGER, MARTIN | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Johns Hopkins University | Baltimore, MD | 167 | $169.6 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 96 | $119.6 million | 0 | $0 |
| Stanford University | Stanford, CA | 102 | $115.1 million | 0 | $0 |
| University of Washington | Seattle, WA | 79 | $95.8 million | 0 | $0 |
| Duke University | Durham, NC | 104 | $93.6 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 65 | $84.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 67 | $81.9 million | 0 | $0 |
| Jaeb Center for Health Research, Inc. | Tampa, FL | 3 | $80.8 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 63 | $78.3 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 71 | $76.1 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 57 | $72.2 million | 0 | $0 |
| Washington University | Saint Louis, MO | 58 | $70 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 53 | $68.8 million | 0 | $0 |
| Massachusetts Eye and Ear Infirmary | Boston, MA | 47 | $65.4 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 63 | $65.3 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 58 | $65 million | 0 | $0 |
| Schepens Eye Research Institute | Boston, MA | 60 | $62.7 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 69 | $62.1 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 35 | $61.7 million | 0 | $0 |
| University of Rochester | Rochester, NY | 54 | $61.3 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 56 | $61.2 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 38 | $59.8 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 53 | $59.2 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 38 | $58.8 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 44 | $58.2 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 55 | $51.7 million | 0 | $0 |
| Yale University | New Haven, CT | 50 | $51.5 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 33 | $47.2 million | 0 | $0 |
| Ohio State University | Columbus, OH | 44 | $45.1 million | 0 | $0 |
| University of California at Davis | Davis, CA | 43 | $43.6 million | 0 | $0 |
| University of Chicago | Chicago, IL | 26 | $43.1 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 49 | $42.9 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 50 | $41.6 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 39 | $41.2 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 13 | $40.4 million | 0 | $0 |
| University of Houston | Houston, TX | 31 | $39.6 million | 0 | $0 |
| Wayne State University | Detroit, MI | 37 | $38.7 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 29 | $35.3 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 35 | $33.4 million | 0 | $0 |
| The Emmes Company, LLC | Rockville, MD | 3 | $33.2 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 41 | $32.6 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 28 | $31.9 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 32 | $30.9 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 28 | $30.3 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 38 | $29.9 million | 0 | $0 |
| European Molecular Biology Laboratory | Heidelberg | 1 | $29.1 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 30 | $28.2 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 27 | $27.5 million | 0 | $0 |
| University of Florida | Gainesville, FL | 29 | $27.3 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 23 | $26.6 million | 0 | $0 |
| Augusta University | Augusta, GA | 32 | $25.9 million | 0 | $0 |
| New York University | New York, NY | 28 | $24.4 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 24 | $24.3 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 12 | $24.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 21 | $23.9 million | 0 | $0 |
| West Virginia University Research Corporation | Morgantown, WV | 15 | $23.7 million | 0 | $0 |
| Indiana University | Bloomington, IN | 22 | $23.1 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 32 | $22.2 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 29 | $21.9 million | 0 | $0 |
| Digital Infuzion, Inc. | Rockville, MD | 1 | $21.7 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 19 | $20.2 million | 0 | $0 |
| Upstate Medical University | Syracuse, NY | 25 | $19.8 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 24 | $19.4 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 31 | $19.4 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 22 | $19.3 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 13 | $19.2 million | 0 | $0 |
| Emory University | Atlanta, GA | 26 | $19 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 16 | $18.6 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 18 | $18.3 million | 0 | $0 |
| University of Louisville | Louisville, KY | 23 | $18.1 million | 0 | $0 |
| University of North Texas HLTH Sci CTR | Fort Worth, TX | 20 | $17.6 million | 0 | $0 |
| Brown University | Providence, RI | 20 | $17.6 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 15 | $17.1 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 15 | $17 million | 0 | $0 |
| University of California-Santa Barbara | Santa Barbara, CA | 17 | $16.5 million | 0 | $0 |
| Georgia Tech Research Corporation | Atlanta, GA | 22 | $16.4 million | 0 | $0 |
| Salk Institute for Biological Studies | La Jolla, CA | 12 | $16.2 million | 0 | $0 |
| Allen Institute | Seattle, WA | 5 | $15.9 million | 0 | $0 |
| Doheny Eye Institute | Pasadena, CA | 14 | $15.8 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 17 | $15.5 million | 0 | $0 |
| Smith-Kettlewell Eye Research Institute | San Francisco, CA | 14 | $14.4 million | 0 | $0 |
| State College of Optometry | New York, NY | 14 | $14 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 10 | $13.5 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 12 | $13.4 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 11 | $13.4 million | 0 | $0 |
| Columbia University | New York, NY | 19 | $13.1 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 9 | $12.9 million | 0 | $0 |
| University of South Florida | Tampa, FL | 13 | $12.8 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 11 | $12.4 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 10 | $12.2 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 12 | $12.1 million | 0 | $0 |
| Oklahoma Medical Research Foundation | Oklahoma City, OK | 13 | $12 million | 0 | $0 |
| California Institute of Technology | Pasadena, CA | 8 | $11.8 million | 0 | $0 |
| Amydis Diagnostics, Inc. | La Jolla, CA | 6 | $11.8 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 10 | $11.5 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 9 | $11.4 million | 0 | $0 |
| Northwestern University | Chicago, IL | 12 | $11.3 million | 0 | $0 |
| George Washington University | Washington, DC | 7 | $11.3 million | 0 | $0 |
| Purdue University | West Lafayette, IN | 12 | $10.8 million | 0 | $0 |
| University of Delaware | Newark, DE | 10 | $10.3 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1,837 | $894,632,550 | 0 | $0 |
| 2024 | 1,979 | $909,002,162 | 0 | $0 |
| 2023 | 2,000 | $933,369,028 | 0 | $0 |
| 2022 | 2,020 | $863,722,751 | 0 | $0 |
| 2021 | 1,986 | $828,928,754 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.